Introduction {#s1}
============

Precise neural connectivity underlies the structural organization and function of the nervous system. In the nervous systems of diverse organisms neural connections are arranged into layered networks, wherein each layer is defined by a unique cellular composition and the axonal arborizations of different input neurons are restricted to specific layers. This organizational strategy is thought to optimize the precision of synaptic connectivity and information processing. Layered connections define many regions of the vertebrate nervous system, including the cerebral cortex (mammals), the spinal cord and retina, and connections in the insect optic lobe are also organized in a layer-specific manner. Elucidating how neurons organize into layered networks is crucial for understanding how the precision of neural connectivity is achieved, and may provide key insights into neural function.

Previous studies in both vertebrates and invertebrates have identified molecules that are necessary for layer specificity in particular neuron types (reviewed in) ([@bib2]; [@bib14]; [@bib30]; [@bib31]). However, the molecular mechanisms governing the assembly of specific layers remain poorly characterized. For example, how different neurons innervate the same layer, and whether they do so through shared or different mechanisms is not known. To address this, we study layer formation in the *Drosophila* visual system, wherein the cell types that innervate specific layers are well-described and genetically accessible.

In the *Drosophila* optic lobe ([Figure 1A](#fig1){ref-type="fig"}), visual input converges on the medulla, wherein it is processed within parallel layers. The medulla receives input directly from R7 and R8 photoreceptors, which are UV and blue/green sensitive, respectively, and indirectly from broadly tuned photoreceptors (R1-R6) through second order lamina monopolar neurons L1-L5 (lamina neurons). Photoreceptor and lamina neuron axons innervate discrete medulla layers and synapse with medulla neurons that process information and transmit signals to higher centers. Information from specific regions of the visual field is processed in modular columnar units, organized perpendicular to the layers. Lamina and photoreceptor axons carrying input from the same point in space converge on targets in the same column. Input from neighboring points in space is processed in neighboring columns, establishing a retinotopic map.

![The *Drosophila* visual system and lamina monopolar neurons.\
(**A**) Anatomy of the *Drosophila* visual system (Adapted from [@bib8]). The optic lobe comprises four consecutive neuropil regions called the lamina, medulla, lobula and lobula plate. (**B**) Cartoon of lamina neuron axons in adult flies. The nearly mutually exclusive axonal arborizations of lamina neurons help define layers M1-M5. (**C**) Cartoon of lamina neuron growth cones in early pupal development. Prior to innervating discrete layers, lamina growth cones terminate in broad distal or proximal domains within the outer medulla.](elife-33962-fig1){#fig1}

The medulla comprises ten layers (M1-M10) organized into outer (M1-M6) and inner (M8-M10) regions that are divided by tangential processes that form the serpentine layer (i.e. M7) ([@bib8]) ([Figure 1A](#fig1){ref-type="fig"}). The cell bodies of medulla neurons are excluded from the layers, and thus layered connections develop within a dense meshwork of cellular processes. Laminar-specific connections within the inner plexiform layer (IPL) of the vertebrate retina develop in a similar manner. Medulla layers are defined in adult flies by the morphologies of the axon terminals and dendritic branches of particular cell types, which in general overlap completely or not at all ([Figure 1B](#fig1){ref-type="fig"}). The positions of these processes are largely indicative of the location of synapses, although some neurites do not stratify and form synapses en passant ([@bib37], [@bib38], [@bib39]). In total, \~40,000 neurons that fall into more than sixty cell types form connections within one or more layers ([@bib8]).

Studies of lamina neuron and photoreceptor axon development indicate that medulla layers emerge dynamically from broad domains. The morphologies of L1-L5 axons define layers M1-M5 in the outer medulla of adult animals ([@bib8]) ([Figure 1B](#fig1){ref-type="fig"}). However, in early pupal development the outer medulla is a fraction of its adult size, and lamina growth cones terminate in two broad domains ([Figure 1C](#fig1){ref-type="fig"}) ([@bib24]; [@bib26]). L2 and L4 growth cones terminate in a distal domain of the outer medulla, while L1, L3 and L5 growth cones terminate in a proximal domain. The mechanisms underlying specificity for the distal or proximal domain are not known. Nevertheless, these findings indicate that lamina neurons innervate broad domains prior to segregating into discrete layers. In the mouse IPL, it has been proposed that neurons initially innervate broad domains defined by the complementary expression of repulsive cell surface molecules ([@bib20]). Together with studies in the medulla, this suggests that the refinement of broad domains into discrete layers may represent a conserved developmental strategy for constructing layer-specific circuits.

Characterization of the targeting of L3 axons and the axons of R8 photoreceptors to the M3 layer has provided insight into how discrete layers emerge from broad domains. L3 and R8 axons innervate M3 sequentially during development. R8 neurons are born first and project axons that terminate near the distal surface of the medulla (known as M0) ([@bib43]). L3 axons within the same column project past R8 axons and terminate within a broad domain in the proximal outer medulla (discussed above) ([@bib24]; [@bib26]). Subsequently, L3 growth cones segregate into the developing M3 layer through a stereotyped structural rearrangement that is regulated by mechanisms that are not well understood ([@bib26]). Within M3, L3 growth cones secrete Netrin, which acts locally to regulate the attachment of R8 growth cones within the layer after they extend from M0 ([@bib1]; [@bib25]; [@bib42]). Thus, the M3 layer develops in part through the stepwise innervation of L3 and R8 axons, and R8 layer specificity depends on a signal from L3 growth cones.

Taken together, these developmental studies point to a model, wherein outer medulla layers emerge in a stepwise manner from broad domains through a precise sequence of interactions between specific cell types. To gain insight into the molecular mechanisms that control stepwise layer assembly we concentrate on assembly of the M3 layer, and in this study focus on L3 neurons. Previously, we found that *Drosophila* Fezf (dFezf)/Earmuff, the *Drosophila* ortholog of the Fezf zinc finger transcription factors in vertebrates (Fezf1/2) ([@bib12], [@bib13]; [@bib19]; [@bib27]; [@bib46]), is selectively expressed in L3 neurons in the lamina ([@bib40]). Thus, we reasoned that dFezf might regulate the expression of genes that control cell-specific aspects of L3 development, including broad domain specificity, layer specificity, and synaptic specificity within the target layer.

Interestingly, our genetic analyses of dFezf function in L3 neurons revealed a critical role for dFezf in regulating the M3-specific innervation of both L3 *and* R8 axons. DFezf functions cell autonomously to promote the targeting of L3 growth cones to the proximal domain of the outer medulla, which is essential for L3 layer specificity. We find that members of the dpr cell surface gene family ([@bib23]) are prominent direct or indirect dFezf targets in L3 neurons, and we propose that dFezf regulates growth cone targeting by controlling the expression of dpr proteins that mediate interactions with target cells in the medulla. In addition, we show that dFezf non-autonomously regulates R8 layer specificity through the activation of *Netrin* expression in L3 neurons. When dFezf function is lost in L3 neurons, L3 and R8 axons innervate inappropriate layers while the dendrites of a common synaptic target (Tm9) innervate the M3 layer normally. As a result, synaptic connectivity with the target cell is disrupted. We conclude that dFezf represents a transcriptional module that constructs M3 layer circuitry by controlling the stepwise layer innervation of specific cell types through cell-intrinsic and cell-extrinsic mechanisms. We propose that the use of such modules to coordinate neural connections within correct layers is a widespread strategy for building laminar-specific circuits.

Results {#s2}
=======

DFezf is selectively expressed in L3 neurons during pupal development and in adult flies {#s2-1}
----------------------------------------------------------------------------------------

As a first step towards characterizing the function of dFezf in L3 neurons we examined its expression during development. Previously, we showed that dFezf is expressed in L3 neurons at 40 hr after puparium formation (h APF) ([@bib40]), when L3 growth cones are in the process of segregating into the developing M3 layer ([@bib26]). To assess if dFezf is also expressed in L3 neurons at other stages of development and determine whether expression remains restricted to L3 neurons, we assessed dFezf immunostaining in the lamina using confocal microscopy. We discovered that dFezf is expressed in L3 neurons from early pupal stages (at least as early as 12 hr APF) through to adulthood, but is not expressed in late third instar larvae when lamina neurons begin to differentiate ([Figure 2A--D](#fig2){ref-type="fig"}). DFezf expression was not detected in lamina neuron precursor cells or any other cells besides L3 at any stage of development in the lamina. The timing and selectivity of dFezf expression is consistent with dFezf playing an important role in regulating L3 development.

![*DFezf* is cell autonomously required for L3 layer specificity and axon terminal morphology.\
(**A--D**) Confocal images showing dFezf protein expression in the lamina from the late 3^rd^ Instar larval stage through to adulthood (newly eclosed flies). DFezf expression (green) was observed through immunohistochemistry using a specific antibody. Elav immunostaining (blue) labels all lamina neurons (LNs). At least five brains were examined per time point. Scale bar = 5 microns and applies to all images. (**A**) DFezf (green) is not expressed in the lamina during the 3^rd^ Instar larval stage. Lamina neurons (blue) differentiate in close proximity to R1-R6 axons (white, mAB24B10) forming columnar-like cartridges oriented orthogonally to the lamina plexus (thick white band) comprising R1-R6 terminals. (**B--D**) DFezf (green) is expressed exclusively in L3 neurons in the lamina during pupal development and in newly eclosed adults. L3 neurons (magenta) express myr::GFP (anti-GFP) driven by 9--9 GAL4 ([@bib24]). Asterisks in (**B**) indicate dFezf-expressing lamina neurons (green + blue) that are most likely L3 neurons that have yet to turn on GAL4 expression (youngest L3 neurons). (**E--N**) MARCM + STaR experiments in adult flies. See Materials and methods section for a detailed description. Scale bars when shown are five microns with the exception of the scale bar shown in (**E**), which is twenty microns. L3 clones (green) expressed myr::tandem Tomato (tdTomato) and were visualized using a DsRed antibody. (**E**) Broad view (confocal image) of the morphologies of wild type L3 clones (green) in the lamina and medulla, which are indicated by R1-R8 axons (magenta, mAB24B10). Boxed regions indicate examples of the regions shown in confocal images in F-I, M and N. (**F--I**) Confocal images of terminals from wild type or *dFezf^1^* L3 neurons (green), within the outer medulla (M1-M6), defined by R7 and R8 axons (magenta, mAB24B10). (**J**) Adult MARCM quantification. N is the total number of neurons counted per genotype. 10 brains were analyzed for each genotype. (**K, L**) Confocal images show L3 clones (magenta) within the outer medulla and, within L3 terminals, Brp (green) expression and localization. Brp expressed from its native promoter within a bacterial artificial chromosome (BAC) was selectively tagged with smFPV5 in L3 MARCM clones, and visualized using an anti-V5 antibody. N-Cadherin (CadN) immunostaining (blue) serves as a neuropil marker. All *dFezf^1^* L3 neurons displayed Brp puncta in their terminals. At least five brains were analyzed for each genotype. (**M and N**) Morphologies of dendrites from wild type or *dFezf^1^* L3 neurons in the lamina. The lamina is indicated by R1-R6 axons (magenta, mAB24B10). (**O--Q**) MARCM experiments analyzed at 24 or 48 hr APF. *DFezf^1^* L3 clones (green) express myr::GFP (9--9 GAL4) and are visualized using a GFP antibody. Co-labeling of L3 somas and transcription factors specific for other lamina neuron subtypes (using specific antibodies) show that the mutant neurons do not express these proteins. (**P and Q**) R1-R6 axons (blue, mAB24B10) demarcate lamina cartridges and the lamina plexus.\
10.7554/eLife.33962.004Figure 2---source data 1.Input data for bar graph [Figure 2J](#fig2){ref-type="fig"}.](elife-33962-fig2){#fig2}

DFezf is cell autonomously required for L3 layer specificity {#s2-2}
------------------------------------------------------------

To investigate the function of *dFezf* in L3 neurons we used mosaic analysis with a repressible cell marker (MARCM) ([@bib17]) in conjunction with synaptic tagging with recombination (STaR) ([@bib6]). This allowed us to generate single, fluorescently labeled wild type or *dFezf* mutant L3 neurons while simultaneously visualizing the active zone protein Bruchpilot (Brp), expressed from its native promoter (see Materials and methods for detailed description). The *dFezf* null allele used in these experiments (*dFezf^1^*) contains a single A to T nucleotide change leading to the substitution of a leucine for a conserved histidine in the third zinc-finger domain ([@bib46]). We found that L3 neurons homozygous for *dFezf^1^* displayed defects in axon terminal morphology and layer specificity in the medulla. Wild type L3 neurons elaborate stratified axon terminals within the M3 layer (100%) ([Figure 2E,F,J](#fig2){ref-type="fig"}). The large majority (84%) of the axons of *dFezf^1^* L3 neurons terminated inappropriately within layers distal to M3 (i.e. M1-M2) ([Figure 2G,J](#fig2){ref-type="fig"}) and had abnormally shaped terminals (compare [Figure 2F and G](#fig2){ref-type="fig"}). The remaining 16% of the axons either terminated in the M3 layer ([Figure 2H,J](#fig2){ref-type="fig"}) or in more proximal layers (e.g. M4-M6) ([Figure 2I,J](#fig2){ref-type="fig"}), and these also had terminal-like swellings in M1-M2 ([Figure 2H,I](#fig2){ref-type="fig"}). Presynaptic Brp puncta were present in mis-targeting L3 terminals ([Figure 2K,L](#fig2){ref-type="fig"}), suggesting that mutant neurons formed synaptic connections within incorrect layers. However, whether these represent active synapses, and if so whether they are established with appropriate partners, inappropriate partners, or both is unclear. In the lamina, L3 neurons display a unique dendritic projection pattern in which all dendrites project to one side of the neurite ([Figure 2M](#fig2){ref-type="fig"}). Dendritic processes were largely normal in *dFezf* null neurons (compare [Figure 2M and N](#fig2){ref-type="fig"}). In addition, the mutant L3 neurons did not express transcription factors specific to other lamina neurons ([Figure 2O--Q](#fig2){ref-type="fig"}) and still expressed L3-specific markers early in development (see [Figure 3](#fig3){ref-type="fig"}), showing that disrupting *dFezf* did not cause an obvious change in cell fate. However, some L3-specific genes are downregulated in *dFezf^1^* L3 neurons, and genes expressed in other lamina neurons become upregulated (see below). Taken together, these findings demonstrate that *dFezf* is cell autonomously required for proper axon terminal morphology and layer specificity, yet dispensable for dendrite formation.

![*DFezf* is required for the targeting of L3 growth cones to the proximal domain of the outer medulla.\
(**A--R**) MARCM experiments analyzed at 24 or 48 hr APF. L3 clones expressed myr::GFP driven by 9--9 GAL4 and were visualized in confocal images using a GFP antibody. In confocal images, mAB24B10 (magenta) was used to label photoreceptor axons, which demarcate the lamina and medulla. Within the medulla, mAB24B10 labels R8 and R7 growth cones, which define the boundaries of the outer medulla. In some images R7 growth cones may appear faint. This reflects normal variations in antibody staining between brains of slightly different ages (e.g. ±2 hr). No defects in photoreceptor axon targeting were observed in these experiments. (**A**) Broad view of the morphologies of wild type L3 clones (green) within the lamina and medulla (indicated by R1-R8 axons, magenta \[mAB24B10\]) at 24 hr APF. The solid boxed region indicates an example of confocal images shown in B-D. The dashed boxed region shows an example of a newly born L3 clone in the most lateral part of the medulla array similar to N and O. M-L indicates medial and lateral. Scale bar = 20 microns. (**B--D, G--J, M--Q**) Confocal images show a zoomed in view of L3 growth cones within the outer medulla. At these stages of development the boundaries of the outer medulla are defined by R7 and R8 growth cones (magenta, mAB24B10). Scale bars = 5 microns. (**E, K, L, R**) Quantification of MARCM experiments. N is the total number of neurons per genotype that were counted. (**E**) WT (seven brains), *dFezf^1^* (12 brains), *CadN, Sema-1a, dFezf^1^* (two brains). (*all*) means that all L3 clones were counted while (*yng*) indicates that the L3 clones present within the most lateral five medulla columns containing R7 growth cones were counted (i.e. youngest L3 clones). Prox. OM = proximal domain of the outer medulla, Distal OM = distal domain of the outer medulla. (**F**) Broad view of the morphologies of wild type L3 clones in the lamina and medulla (indicated by R1-R8 axons, magenta \[mAB24B10\]) at 48 hr APF. The solid boxed region is an example of regions shown in confocal images in G-J. Scale bar = 20 microns. (**I and J**) Arrowheads indicate abnormal swellings within the developing M1-M2 layers. (**K**) Wild type (six brains), *dFezf^1^* (six brains). (**L**) Prox. OM = proximal domain of the outer medulla, Distal OM = distal domain of the outer medulla. (**P and Q**) Arrowheads indicate the depths within the medulla at which L3 growth cones terminate. The serpentine layer (indicated in Q) lies directly beneath the outer medulla. (**R**) *CadN, Sema-1a* (two brains), *CadN, Sema-1a, dFezf^1^* (two brains).\
10.7554/eLife.33962.008Figure 3---source data 1.Input data for bar graphs [Figure 3E, K, L, R](#fig3){ref-type="fig"}, and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}; [Figure 3---figure supplement 2B,2D and 2F](#fig3s2){ref-type="fig"}.](elife-33962-fig3){#fig3}

DFezf is necessary for targeting to the proximal domain of the outer medulla {#s2-3}
----------------------------------------------------------------------------

To determine how disrupting *dFezf* affects L3 axon targeting during development, we compared the axonal morphologies of wild type and *dFezf^1^* neurons during pupal development using MARCM. In early pupal development (\~24 hr APF), the axons of wild type L3 neurons terminate in the proximal domain of the outer medulla directly above R7 growth cones ([Figure 3A,B,E](#fig3){ref-type="fig"}). The axons of *dFezf^1^* neurons incorrectly terminated within the distal domain of the outer medulla ([Figure 3C--E](#fig3){ref-type="fig"}). Under these conditions L3 growth cones terminated just underneath the growth cones of R8 photoreceptors ([Figure 3C](#fig3){ref-type="fig"}), and occasionally terminated slightly more distally so that they completely overlapped with R8 growth cones ([Figure 3D](#fig3){ref-type="fig"}). By mid-pupal development (\~48 hr APF), the growth cones of wild type L3 neurons have segregated into the developing M3 layer ([Figure 3F,G,K](#fig3){ref-type="fig"}). However, we found that all of the growth cones of *dFezf^1^* L3 neurons displayed abnormal morphologies, defects in layer specificity, or both. Most of the abnormal growth cones (67%) exclusively innervated the developing M1 and M2 layers ([Figure 3H,K](#fig3){ref-type="fig"}). The remaining 33% of the growth cones terminated in the developing M3 layer ([Figure 3I,K](#fig3){ref-type="fig"}) or in more proximal layers (e.g. M4-M6) ([Figure 3J,K](#fig3){ref-type="fig"}). However, each of these growth cones also displayed abnormal swellings in distal layers (i.e. the developing M1 and M2 layers) ([Figure 3I,J](#fig3){ref-type="fig"}, arrowheads). These defects in morphology and layer innervation are consistent with the abnormalities observed in adult flies under these conditions. We observed similar deficits in L3 growth cone targeting in MARCM experiments when we used a different *dFezf* mutant allele (*dFezf^2^*) that eliminates the entire *dFezf* open reading frame ([@bib46]) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Moreover, defects in growth cone targeting during pupal development, as well as abnormal layer innervation in adult flies caused by *dFezf^1^* or *dFezf^2^* were completely rescued by a single copy of a bacterial artificial chromosome (BAC) containing the *dFezf* locus ([Figure 3L,M](#fig3){ref-type="fig"}, and [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). Together, these findings demonstrate that *dFezf* is cell-autonomously required for the targeting of L3 growth cones to the proximal domain of the outer medulla, which may be necessary for the subsequent segregation of the growth cones into the developing M3 layer.

We reasoned that the growth cones of *dFezf* null L3 neurons could directly terminate within the distal domain of the outer medulla, or could initially target correctly to the proximal domain and then retract. Direct mis-targeting would be consistent with a change in axon target specificity, while retraction would suggest a defect in stabilizing growth cone position. To distinguish between these possibilities we took two approaches. First, in MARCM experiments we focused on the L3 clones that had most recently innervated the medulla (i.e. the youngest clones, see dashed box in [Figure 3A](#fig3){ref-type="fig"}). Unlike the youngest wild type clones, the large majority of the nascent *dFezf^1^* clones (82%) terminated within the distal domain of the outer medulla similar to their older counter parts ([Figure 3E,N,O](#fig3){ref-type="fig"}), consistent with most of these neurons directly innervating this region. Second, we investigated growth cone targeting when *dFezf* was disrupted in combination with *CadN* and *Sema-1a*. CadN and Sema-1a function synergistically to restrict L3 growth cones to the outer medulla during pupal development, preventing innervation of the serpentine layer and inner medulla ([@bib26]). We hypothesized that if the growth cones of *dFezf^1^* L3 neurons initially target correctly and then retract, then in the absence of CadN and Sema-1a function the growth cones would inappropriately innervate the serpentine layer and inner medulla, as in *CadN* and *Sema-1a* double mutant neurons. Conversely, if the growth cones of *dFezf^1^* L3 neurons directly mis-target to the distal outer medulla, this should prevent mis-targeting beyond the outer medulla caused by the loss of CadN and Sema-1a function, and the triple KO phenotype should resemble the loss of dFezf function only. MARCM experiments revealed the latter to be correct. L3 neurons lacking the function of dFezf, CadN and Sema-1a predominantly innervated the distal domain of the outer medulla in early pupal development ([Figure 3E,P](#fig3){ref-type="fig"}), similar to L3 neurons lacking dFezf function only ([Figure 3C--E](#fig3){ref-type="fig"}), although the triple KO neurons more frequently terminated within the R8 growth cone layer. Importantly, the triple KO neurons did not mis-target beyond the outer medulla like *CadN*/*Sema-1a* double mutant L3 neurons ([Figure 3Q,R](#fig3){ref-type="fig"}). Combined with our analyses of newly born *dFezf^1^* L3 neurons, these data suggest that L3 neurons lacking dFezf function directly innervate the distal domain of the outer medulla, which is consistent with a switch in broad domain specificity.

DFezf acts instructively to regulate growth cone targeting to the proximal domain of the outer medulla {#s2-4}
------------------------------------------------------------------------------------------------------

DFezf could function permissively or in an instructive manner to regulate the targeting of L3 growth cones to the proximal domain of the outer medulla. To discriminate between these possibilities we performed mis-expression experiments in other lamina neurons. If dFezf function is instructive, then mis-expressing it in L2 or L4 neurons, which normally target to the distal domain of the outer medulla ([Figure 1C](#fig1){ref-type="fig"}), should cause their growth cones to terminate in the proximal domain. By contrast, as L1 and L5 growth cones normally terminate in the proximal domain ([Figure 1C](#fig1){ref-type="fig"}), dFezf-mis-expression in these neurons should not affect growth cone targeting. For technical reasons we decided to focus on L2 and L5 neurons. In L5 neurons, we mis-expressed cDNA encoding dFezf-HA using 6--60 GAL4, which has been shown to selectively drive expression in L5 neurons in the lamina ([@bib24]). In these experiments all L5 neurons and a small number of medulla and lobula neurons expressed dFezf-HA, as determined through HA immunostaining ([Figure 4A](#fig4){ref-type="fig"}, and [Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), and a subset of L5 neurons were specifically labeled by myr::GFP ([Figure 4A](#fig4){ref-type="fig"}). We found that the expression of dFezf-HA had no effect on L5 growth cone position in early pupal development. The growth cones of dFezf-expressing L5 neurons innervated the proximal domain of the outer medulla in a manner indistinguishable from wild type neurons ([Figure 4B--D](#fig4){ref-type="fig"}). In adult flies, L5 terminals are confined to the M5 layer, and L5 neurons also arborize within distal layers M1 and M2 through branching that occurs off the main neurite during mid-late pupal development ([Figure 4E](#fig4){ref-type="fig"}). DFezf expression did not affect the layer position or morphology of L5 terminals, but caused defects in the distal arborizations of the vast majority of L5 neurons ([Figure 4F--H](#fig4){ref-type="fig"}). 82% of L5 neurons mis-expressing dFezf displayed reduced distal arborizations that failed to extend into the M2 layer ([Figure 4F,H](#fig4){ref-type="fig"}), and 15% of neurons extended distal branches into neighboring columns ([Figure 4G,H](#fig4){ref-type="fig"}). These findings, along with the fact that *dFezf* null L3 neurons inappropriately arborize in distal medulla layers, suggests that dFezf function may antagonize innervation of the distal outer medulla.

![DFezf plays an instructive role in regulating growth cone targeting.\
(**A--H**) L5 mis-expression experiments. DFezf-HA was expressed in L5 neurons using 6--60 GAL4, and sparse labeling of L5 neurons (myr::GFP, α-GFP) was achieved using the FlpOut method (see Materials and methods for detailed description). (**A**) DFezf-HA (magenta) is expressed in all L5 neurons, a subset of which are labeled with myr::GFP (green) using FlpOut. L5 neurons are easily identified based on position, as their somas are located directly distal to the lamina plexus defined by R1-R6 axons (blue, mAB24B10), which appears as a thick band. (**B and C**) Confocal images of L5 growth cones (green) within the outer medulla at 24 hr APF. R7 and R8 growth cones (blue, mAB24B10) define the boundaries of the outer medulla. (**D**) Quantification of L5 mis-expression experiments at 24 hr APF. N = the number of cells counted. (**E--G**) Confocal images of L5 axons (green) within the outer medulla in adult flies. Outer medulla layers are identified using R8 and R7 axons (mAB24B10, blue) as a reference. (**H**) Quantification of L5 mis-expression experiments in adult flies. N = the number of cells counted. (**I--O**) Mis-expression of dFezf-HA in L2 neurons in MARCM experiments. DFezf-HA was expressed in lamina neuron clones (green, myr::GFP: α-GFP) by 11--164 GAL4 ([@bib24]). L2 neurons (magenta) were labeled with myr::tdTomato (α-DsRed) driven by 16H03-LexA. L2 MARCM clones are double positive for myr::GFP and myr::tdTomato and appear white. (**I--I'''**) DFezf-HA (blue, α-HA) is expressed in L2 MARCM clones (white) that are double positive for myr::GFP and myr::tdTomato. (**J and K**) Confocal images showing L2 growth cone targeting within the outer medulla at 24 hr APF. R7 and R8 growth cones (blue, mAB24B10) define the boundaries of the outer medulla. Scale bar = 5 microns. (**L**) Quantification of L2 mis-expression experiments at 24 hr APF. N = the number of cells counted. (**M and N**) Confocal images showing L2 axon targeting within the outer medulla in adult flies. R7 and R8 axons (blue, mAB24B10) define outer medulla layers. Scale bar = 5 microns. (**O**) Quantification of L2 mis-expression experiments in adult flies. N = the number of cells counted.\
10.7554/eLife.33962.011Figure 4---source data 1.Input data for bar graphs [Figure 4D, H, L, and O](#fig4){ref-type="fig"}.](elife-33962-fig4){#fig4}

To assess the effects of mis-expressing *dFezf* in L2 neurons, we expressed cDNA encoding dFezf-HA in lamina neurons using a pan-lamina neuron GAL4 driver (11--164 GAL4) in MARCM experiments, and labeled L2 neurons using an L2-specific LexA driver (16H03-LexA). The expression of dFezf-HA was assessed through HA immunostaining ([Figure 4I--I'''](#fig4){ref-type="fig"}). In these experiments, GAL80 prevented GAL4 expression (and therefore dFezf-HA expression) in lamina neurons that did not undergo mitotic recombination (non-clones), which represented the large majority of lamina neurons. In lamina neuron clones GAL4 induced the expression of dFezf-HA and GFP, and the GFP positive clones that also expressed the L2 marker were confirmed as L2 clones. Only isolated L2 clones within each column were considered, eliminating the possibility of non-autonomous effects from dFezf mis-expression in other lamina neurons in the same column. Using this criteria we found that, in early pupal development, the growth cones of all L2 neurons mis-expressing dFezf-HA inappropriately terminated within the proximal domain of the outer medulla ([Figure 4J--L](#fig4){ref-type="fig"}), and in adult flies the large majority of these neurons (88%) incorrectly innervated the M3 layer ([Figure 4M--O](#fig4){ref-type="fig"}). Similar results were found in MARCM experiments wherein a sparser distribution of lamina neuron clones was generated, and only dFezf-HA expressing L2 neurons that were isolated in the home column *and* not next to lamina neuron clones in neighboring columns were considered ([Figure 4---figure supplement 1B--D](#fig4s1){ref-type="fig"}). In all cases dFezf-HA expressing L2 neurons still displayed terminal-like swellings within the M2 layer, indicating a partial rather than complete change in layer specificity. These experiments demonstrate that mis-expressing *dFezf* in L2 neurons is sufficient to induce innervation of the proximal domain of the outer medulla, and cause ectopic innervation of the L3 target layer M3. Collectively, our mis-expression studies in L2 and L5 neurons support that dFezf acts instructively to direct growth cone targeting. We hypothesize that dFezf achieves this by antagonizing innervation of the distal outer medulla and promoting innervation of the proximal outer medulla (see discussion).

DFezf regulates a complex program of cell surface gene expression {#s2-5}
-----------------------------------------------------------------

To gain insight into the mechanism by which dFezf regulates L3 growth cone targeting, we sought to identify genes that are differentially expressed between wild type and *dFezf* null L3 neurons, as these would represent candidate direct or indirect dFezf targets. To accomplish this, we isolated fluorescently labeled wild type or *dFezf* null L3 MARCM clones by FACS at 40 hr APF ([Figure 5A,B](#fig5){ref-type="fig"}), prepared cDNA libraries, and sequenced the libraries using an Illumina platform. Five replicates were performed for wild type and mutant genotypes, and to minimize technical variability all ten cDNA libraries were prepared and sequenced at the same time ([Supplementary file 1](#supp1){ref-type="supplementary-material"} contains normalized counts for all samples and genes). Quality control analyses show that the RNA-seq data are of a high caliber and that differences between samples are primarily attributed to genotype ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). Differential expression analysis identified 455 differentially expressed (DE) genes (padj \<0.05) ([Figure 5C](#fig5){ref-type="fig"}, and [Supplementary file 3](#supp3){ref-type="supplementary-material"}), and changes in the expression of several of these were verified at the protein level ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Using previously curated databases ([@bib16]; [@bib40]), we found that 110 of the 455 DE genes are cell surface and secreted genes ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}), consistent with a role for dFezf in regulating cell-cell communication. Large fractions of DE genes were up or downregulated (190 and 265 genes, respectively) (see [Figure 5C](#fig5){ref-type="fig"} and [Supplementary file 2](#supp2){ref-type="supplementary-material"}), indicating that dFezf function serves to both activate and repress gene expression, either directly or through intermediate regulators. This also suggested that defects in growth cone targeting when *dFezf* is disrupted could result from the downregulation of particular genes, the upregulation of genes, or both.

![DFezf regulates a complex program of cell surface gene expression.\
(**A and B**) MARCM was performed to generate and specifically label single wild type or *dFezf^1^* L3 neurons at 40 hr APF. L3 clones were labeled with a nuclear reporter (H2A-GFP) and a transmembrane reporter (myr::tdTomato) by 9--9 GAL4. (**A**) A representative confocal image shows that L3 neurons are the only cell type labeled by both GFP (green) and tdTOM (magenta). Photoreceptor neurons (R1-R8) (blue, mAB24B10) are labeled as a reference for the lamina and medulla. Scale bar = 20 microns. (**B**) A representative FACS plot shows that L3 neurons expressing H2A-GFP and myr::tdTomato separated as a tight cluster from background cells (100K events are shown). (**C**) A heat map (row scaled) of differentially expressed genes that includes data from all samples. Each row represents the normalized expression of a differentially expressed gene, and each column represents a sample. Presenting the data in this manner shows that samples clearly separate based on genotype, and that large fractions of differentially expressed genes are either up or downregulated. (**D**) Table showing *dpr* genes that are differentially expressed between wild type and *dFezf* null L3 neurons. The genes are listed in order of significance (padj). The top three most significant DE genes overall, *dprs 17*, *13*, and *1* are shown in red, and the rest of the genes are shown in green. TPM (transcripts per million mapped reads) values are averages across all samples for a given genotype.](elife-33962-fig5){#fig5}

Since CadN and Sema-1a play a crucial role in L3 growth cone targeting ([@bib24]; [@bib26]), we hypothesized that dFezf might regulate their expression as part of a gene program controlling growth cone position. However, *CadN* and *Sema-1a* mRNA levels in wild type and *dFezf* mutant L3 neurons were not significantly different ([Figure 5---figure supplement 3A,B](#fig5s3){ref-type="fig"}), demonstrating that dFezf is not necessary for their expression at 40 hr APF. In line with this, *CadN* and *Sema-1a* double mutant L3 neurons display defects in dendrite morphology ([Figure 5---figure supplement 3C](#fig5s3){ref-type="fig"}), but dendrites were qualitatively normal in the absence of dFezf function ([Figure 5---figure supplement 3C](#fig5s3){ref-type="fig"}), indicating that disrupting *dFezf* does not affect CadN and Sema-1a function. Together, these data strongly support that dFezf acts in parallel to CadN and Sema-1a to regulate L3 growth cone targeting within the outer medulla (see discussion).

Many genes are differentially expressed between wild type and *dFezf* null L3 neurons, and are thus candidates for regulating growth cone targeting. However, ranking the DE genes based on significance revealed several intriguing candidates. For example, using this criteria, the top three genes are *dprs 17*, *13*, and *1*, respectively, which are members of the dpr cell surface family ([@bib23]). The mRNA levels of all three genes change more than 1000 fold when *dFezf* is disrupted in L3 neurons ([Figure 5D](#fig5){ref-type="fig"}). *Dpr 17* is exclusively expressed in L3 neurons in the lamina and *dpr1* is expressed in L3 and L4 neurons ([@bib40]). Both are downregulated in the absence of dFezf function, and for dpr17 we confirmed this at the protein level ([Figure 5---figure supplement 1A--B'](#fig5s1){ref-type="fig"}). *Dpr13* is highly expressed in L2 neurons and moderately expressed in L4 neurons ([@bib40]), and is upregulated in *dFezf* null L3 neurons. In addition to these, eight other *dpr* genes are differentially expressed between wild type and *dFezf* null L3 neurons ([Figure 5D](#fig5){ref-type="fig"}), suggesting that *dpr* genes are prominent direct or indirect dFezf targets.

Dpr proteins are immunoglobulin (Ig) domain containing cell surface molecules (21 dprs) that bind heterophilically to dpr interacting proteins (DIPs) (9 DIPs) ([@bib3]; [@bib48]), which are also cell surface molecules and members of the Ig superfamily (IgSF). Dpr and DIP proteins are expressed in a matching manner between lamina neurons (including L3) and their synaptic targets in the medulla, and specific dpr-DIP interactions, or combinations of them, have been proposed to encode synaptic specificity ([@bib40]). Thus, one possibility is that dFezf regulates L3 growth cone position by controlling the expression of specific *dpr* genes, whose products mediate interactions with appropriate DIP-expressing target cells in the medulla. In the absence of dFezf function, an abnormal complement of *dprs* is expressed (L3 *dprs* are downregulated and *dprs* expressed by other lamina neurons are upregulated), and this may promote interactions with incorrect target neurons, altering growth cone position and laminar specificity (see discussion).

In summary, a large number of genes change in their levels of expression when *dFezf* is disrupted in L3 neurons, and similar numbers of these are up or downregulated. Nearly a quarter of the DE genes are cell surface and secreted molecules, suggesting that dFezf regulates communication between L3 and other cells. *Dpr* genes are strong candidates for acting downstream of dFezf to regulate growth cone targeting. However, as many candidates exist, additional studies are necessary to identify the genes relevant for this process (see discussion).

DFezf is necessary and sufficient for netrin expression {#s2-6}
-------------------------------------------------------

L3-derived Netrin is necessary for the M3-specific innervation of R8 photoreceptor axons ([@bib25]; [@bib42]). Our RNA-seq analyses revealed that the mRNA levels of *Netrin-A* and *B (NetA/B)* were drastically reduced in *dFezf* null L3 neurons compared to wild type neurons at 40 hr APF ([Figure 5---figure supplement 3A,B](#fig5s3){ref-type="fig"}). This suggested that, in addition to cell autonomously regulating L3 targeting, dFezf non-autonomously regulates R8 layer specificity via activation of *Netrin* expression in L3 neurons. To test this we first assessed Netrin protein expression in L3 neurons during development. Previous gene expression and genetic studies implied that L3 neurons express Netrin protein ([@bib25]; [@bib40]; [@bib42]), but this had not been shown directly. To address this we used a NetB-GFP protein trap, wherein endogenous NetB is tagged with GFP. We focused on NetB protein because *NetB* is expressed at much higher levels than *NetA* in L3 neurons ([Figure 5---figure supplement 3A,B](#fig5s3){ref-type="fig"}) ([@bib40]), and the expression of *NetB* in L3 neurons is sufficient to support proper R8 layer specificity in the background of a *NetA/B* deletion ([@bib42]). At 24 hr APF we observed NetB expression in the perinuclear region of the oldest lamina neurons (most anterior) ([Figure 6A--D'](#fig6){ref-type="fig"}). Using markers specific for different lamina neuron subclasses we discovered that NetB is expressed by L3, L4 and L5 neurons, but not L1 or L2 neurons. We assessed NetB expression in L3 by labeling L3 somata with FLAG-tagged dFezf (dFezf-FLAG) expressed from its native promoter within a BAC ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). At 48 hr APF NetB expression remained specific to L3, L4 and L5 neurons in the lamina, although it was most strongly expressed in L3 neurons at this stage ([Figure 6E--H](#fig6){ref-type="fig"}). Thus, while NetB immunoreactivity is first detected within the M3 layer at \~40 hr APF ([@bib42]), which coincides with the segregation of L3 growth cones into the developing M3 layer, L3 neurons express NetB much earlier in development. In addition, we found that NetB is also expressed by L4 and L5 neurons during pupal development, and thus may regulate circuit assembly within multiple developing layers.

![Cellular expression of NetB in the lamina during pupal development.\
(**A--H**) NetB expression in the lamina at 24 or 48 hr APF. Endogenous NetB was visualized using a NetB-GFP protein trap (α-GFP). All confocal images are representative examples, and at least five brains were examined per genotype. All scale bars = 5 microns. (**A--D'**) In the lamina, lamina neurons are born in a wave (Anterior = oldest, Posterior = youngest). The yellow dashed lines in (**A--C**) indicate the anterior-posterior region of the lamina where NetB expression is first observed. In D and D' anterior-posterior is indicated by A-P. (**A**) At 24 hr APF, NetB (green) was expressed in the anterior side of the developing lamina (to the left of the yellow dashed line) containing the oldest lamina neurons. NetB was expressed in L3 neurons (magenta, dFezf-FLAG). The youngest L3 neurons on the posterior side of the lamina that had not turned on NetB expression are indicated by asterisks. (**B**) At 24 hr APF, NetB (green) was detected in L4 and L5 neurons (magenta, α-bsh) in the oldest region of the lamina (to the left of the yellow dashed line). NetB (green) was not detected in L1 neurons (blue, α-svp, asterisks in the anterior region). (**C**) Consistent with findings shown in B, at 24 hr APF NetB (green) was expressed in the oldest L4 neurons (magenta) in the anterior region of the lamina (left of the dashed yellow line). L4 neurons were labeled using an L4-specific driver (31C06-LexA, LexAop-myr::tdTomato). At this stage 31C06-LexA drives expression in a small population of L4 neurons in the anterior region of the lamina. R1-R6 axons (blue. mAB24B10) provided a reference for the lamina. The image shown here is taken from a pupa that is slightly older than in A and B, as NetB is expressed in nearly all the lamina neurons in the field of view. (**D and D'**) NetB (green) was not expressed in L2 neurons (magenta) at 24 hr APF. L2 neurons were visualized using a specific driver (16H03-LexA, LexAop-myr::tdTomato) that drives expression in the most anterior (oldest) L2 neurons at this stage. R1-R6 axons (blue, mAB24B10) serve as a reference for the lamina. Asterisks show the positions of L2 somas. The image shown here is taken from a pupa that is slightly older than in A and B, as NetB is expressed in all the lamina neurons in the field of view. (**E**) NetB (green) is expressed in all L3 neurons (magenta, dFezf-FLAG) at 48 hr APF. (**F**) All L4 (magenta, 31C06-LexA, LexAop-myr::tdTomato) and L5 (blue, α-Pdm3) neurons express NetB at 48 hr APF. NetB expression in L4 and L5 neurons is weaker than in L3 neurons (green only). (**G**) NetB (green) is not expressed in L1 neurons (magenta, α-Svp) at 48 hr APF. (**H**) NetB (green) is not expressed in L2 neurons (magenta, α-Bab1) at 48 hr APF.](elife-33962-fig6){#fig6}

To test whether dFezf is required for NetB protein expression we examined NetB expression during pupal development when dFezf function was disrupted in L3 neurons. Disrupting *dFezf* in single L3 neurons in MARCM experiments drastically reduced NetB immunostaining in L3 cell bodies at 48 hr APF ([Figure 7A--B'](#fig7){ref-type="fig"}). To assess whether *dFezf* is necessary for NetB expression in the M3 layer, wherein it is thought to be secreted from L3 growth cones, we performed RNAi experiments to disrupt *dFezf* in the vast majority of L3 neurons. The expression of *dFezf* RNAi in the lamina eliminated detectable dFezf immunoreactivity in L3 neurons ([Figure 7C,D](#fig7){ref-type="fig"}), and considerably reduced NetB immunostaining in L3 somas and the developing M3 layer at 48 hr APF ([Figure 7E,F](#fig7){ref-type="fig"}). Together, these experiments demonstrate that *dFezf* is cell autonomously required for NetB protein expression in L3 neurons.

![DFezf non-autonomously regulates R8 layer specificity through activation of *Netrin* expression in L3 neurons.\
(**A--B'**) NetB expression (green, α-NetB) in the somas of wild type or *dFezf^1^* L3 neurons was assessed at 48 hr APF in the lamina in MARCM experiments using confocal microscopy. L3 clones (magenta) expressed myr::GFP (9--9 GAL4) and were visualized using a GFP antibody. (**A--A'**) Asterisks indicate the positions of wild type L3 clones (magenta). The images are representative of NetB expression (green) assessed in five brains. (**A**) R1-R6 axons (blue, mAB24B10) were used as a reference for the lamina. Scale bar = 5 microns. (**B--B'**) Asterisks indicate the positions of *dFezf^1^* L3 clones (magenta). The images are representative of NetB expression (green) assessed in six brains. (**B**) R1-R6 axons (blue, mAB24B10) were used as a reference for the lamina. Scale bar = 5 microns. (**C and D**) *DFezf* RNAi was expressed in lamina neurons and their precursor cells using 9B08-GAL4. DFezf expression (green) in L3 neurons was assessed through immunostaining (α-dFezf). R1-R6 axons (magenta, mAB24B10) provided a reference for the lamina. (**C**) Representative confocal image of dFezf expression in control flies, which include flies containing *dFezf* RNAi only or 9B08-GAL4 (seven brains total). Scale bar = 5 microns. (**D**) Shows a representative confocal image of dFezf expression in knockdown flies (eight brains examined). (**E and F**) NetB (green, α-Net-B) expression in the lamina and within the M3 layer was assessed in control brains and when *dFezf* RNAi was expressed in lamina neurons and their precursors using 9B08-GAL4. R1-R8 axons (magenta, mAB24B10) provided a reference for the lamina and outer medulla. Arrowheads indicate NetB expression in medulla neurons. (**E**) Shows a representative confocal image of NetB expression (green) in control flies, which contain *dFezf* RNAi only or 9B08-GAL4 (four brains total). Net-B was prominently observed in L3 cell bodies in the lamina, within the M3 layer in the medulla and in medulla neuron cell bodies (arrowheads) on a consistent basis. Scale bar = 20 microns. (**F**) A representative confocal image from flies containing *dFezf* RNAi +9B08 GAL4 (six brains). NetB (green) was consistently reduced in L3 cell bodies in the lamina and the M3 layer, but not in medulla neuron cell bodies (arrowheads). (**G--J**) DFezf-HA was expressed broadly in lamina neurons by 11--164 GAL4. (**G and H**) Confocal images of dFezf-HA expression (green, α-HA) in lamina neurons (\~24 hr APF). The lamina was identified by visualizing R1-R6 axons (magenta, mAB24B10). (**G**) Representative confocal image from flies containing DFezf-HA or 11--164 GAL4 only (at least five brains). No HA labeling was detected in the lamina of these flies. (**H**) Shows a representative confocal image from flies containing DFezf-HA +11--164 GAL4 (at least five brains). Prominent HA staining (green) was always observed in the lamina of these flies at 24 hr APF. (**I and J**) Confocal images of NetB expression (green) (NetB-GFP, α-GFP) in the lamina at 48 hr APF. L2 neurons (magenta) were labeled using α-bab1, and R1-R6 axons (blue, mAB24B10) provided a reference for the lamina. (**I**) Representative confocal image from flies containing DFezf-HA or 11--164 GAL4 (four brains). No L2 neurons (magenta) expressed Net-B (green) (n = 308). NetB-expressing cells in the image are L3 neurons. Scale bar = 5 microns. (**J**) Representative confocal image from flies containing DFezf-HA +11--164 GAL4 (four brains). 99% of L2 neurons (magenta) expressed NetB (green) (n = 310). (**K--M**) *DFezf* RNAi was expressed in lamina neurons and their precursors using 9B08-GAL4 and R8 axon targeting was assessed within the outer medulla. (**K and L**) Confocal images showing R8 axon targeting within the outer medulla in adult flies. R8 axons (green) were visualized using an R8-specific marker (Rh6-GFP, α-GFP). L3 axons (magenta) are labeled by 22E09-LexA, LexAop-myr::tdTomato. *DFezf* knockdown inhibits 22E09-LexA activity, and serves as a positive control for the efficacy of *dFezf* RNAi. R7 and R8 axons (blue, mAB24B10) provide a reference for outer medulla layers. (**K**) A representative image from flies containing *DFezf* RNAi or 9B08-GAL4 only (six brains total). Scale bar = 5 microns. (**L**) A representative image from flies containing *DFezf* RNAi +9B08 GAL4 (four brains). Arrowheads indicate the depths at which R8 axons terminate. (**M**) Quantification of R8 axon targeting. N = the number of R8 axons counted.\
10.7554/eLife.33962.019Figure 7---source data 1.Input data for bar graph [Figure 7M](#fig7){ref-type="fig"}.](elife-33962-fig7){#fig7}

To determine if dFezf is sufficient to induce NetB expression, we mis-expressed dFezf-HA in lamina neurons using a pan-lamina GAL4 driver and assessed NetB expression in L2 neurons ([Figure 7G--J](#fig7){ref-type="fig"}). L2 neurons mis-expressing *dFezf* still expressed Bab1 ([Figure 7J](#fig7){ref-type="fig"}), a transcription factor shown to be selectively expressed in L2 neurons in the lamina ([@bib40]), indicating that *dFezf* expression did not cause an obvious change in cell fate. We found that, while no wild type L2 neurons expressed NetB at 48 hr APF ([Figure 7I](#fig7){ref-type="fig"}), 99% of dFezf-HA expressing L2 neurons ectopically expressed NetB ([Figure 7J](#fig7){ref-type="fig"}). Thus, in the context of L2 neurons dFezf is sufficient to induce NetB expression. Collectively, our RNA-seq and protein expression experiments support that dFezf, either directly or through intermediate regulators, activates *Netrin* expression in L3 neurons.

DFezf in L3 neurons is non-autonomously required for R8 layer specificity {#s2-7}
-------------------------------------------------------------------------

To directly determine if dFezf function in L3 neurons is required for R8 layer specificity, as is predicted by its role in regulating *Netrin* expression, we disrupted *dFezf* via RNAi and assessed R8 axon targeting using an R8-specific marker. Normally, R8 axons terminate in the M3 layer ([Figure 7K,M](#fig7){ref-type="fig"}). When *dFezf* was disrupted 45% of R8 axons terminated within inappropriate layers ([Figure 7L,M](#fig7){ref-type="fig"}). 29% of the axons terminated in layers proximal to M3 (i.e. M4-M6) and 16% terminated in distal layers (i.e. M0-M2). The penetrance of mis-targeting in our experiments is similar to that reported by Timofeev and colleagues in a *Netrin* null background (53%) ([@bib42]). However, they reported that only 2% of R8 axons mis-targeted to more proximal layers (versus 29% in our experiments). Differences in R8 mis-targeting between ours and previous experiments could reflect non-specific effects of disrupting dFezf in L3 neurons (e.g. due to mis-targeting L3 axons), or indicate that L3 neurons provide a dFezf-dependent cue in addition to Netrin that is important for the targeting of R8 axons (see discussion). Nonetheless, our experiments show that *dFezf* in L3 neurons is required for R8 layer specificity. Together with previous research, these findings along with our analyses of *Netrin* gene and protein (NetB) expression indicate that dFezf regulates R8 layer specificity, to a large extent, through activation of *Netrin* expression in L3 neurons.

Disrupting dFezf in L3 neurons does not affect the layer innervation of Tm9 neurons {#s2-8}
-----------------------------------------------------------------------------------

Within the M3 layer L3 axons synapse onto the dendrites of transmedullary nine neurons (Tm9) ([@bib9]; [@bib37]; [@bib39]), and synapses between R8 and Tm9 have also been reported ([@bib9]). Tm9 neurons are a subtype of projection neurons that transmit information from the medulla to the lobula neuropil. As disrupting *dFezf* in L3 neurons caused defects in L3 and R8 layer innervation but did not impair the formation of presynaptic sites in L3 neurons ([Figure 2K,L](#fig2){ref-type="fig"}), we assessed whether connectivity with Tm9 neurons is perturbed under these conditions. To test this we used cell-specific drivers to assess overlap between L3 axons and Tm9 dendrites within the same medulla columns during development, under conditions when L3 neurons were wild type or mutant for *dFezf* in MARCM experiments. During early pupal development (\~24 hr APF) in wild type columns, L3 growth cones and Tm9 dendrites targeted to similar depths within the outer medulla, but appeared to be restricted to opposite sides of the column ([Figure 8A,B--B"](#fig8){ref-type="fig"}). In contrast, by mid-pupal development (\~48 hr APF) L3 growth cones and Tm9 dendrites overlapped significantly within the developing M3 layer ([Figure 8C,D--D"](#fig8){ref-type="fig"}). In adult flies L3 terminals were flattened and overlapped with the proximal portion of Tm9 dendrites within the M3 layer ([Figure 8E,F--F"](#fig8){ref-type="fig"}).

![Disrupting dFezf in L3 neurons does not affect the layer innervation of Tm9 neurons.\
(**A--I"**) Confocal images from MARCM experiments analyzed at 24 hr APF, 48 hr APF or in newly eclosed adults. The images shown are representative of neurons assessed from at least five brains per genotype per time-point. L3 clones (green) expressed myr::GFP (9--9 GAL4) and were visualized using a GFP antibody, wild type Tm9 neurons (magenta) expressed myr::tdTomato (24C08-LexA) and were visualized with a DsRed antibody. R1-R8 axons (blue, mAB24B10) define the lamina and outer medulla. (**A, C, E**) Broad views showing the entire lamina and medulla and the morphologies of wild type L3 (green) and Tm9 neurons (magenta). The solid boxed regions show examples of the regions of the outer medulla shown in B-B', D-D', F-F', G-G', H-H', and I-I'. (**B, D, F, G, H, I**) Dashed lines indicate the estimated boundaries of a medulla column using R7 and R8 axons (blue) as a reference. (**F and F'', I and I'**) Asterisks mark the positions of medulla columns containing L3 clones.](elife-33962-fig8){#fig8}

When *dFezf* was disrupted in L3 neurons the positions of L3 growth cones and Tm9 dendrites within the same columns were altered in early pupal development ([Figure 8G--G"](#fig8){ref-type="fig"}). Frequently, the growth cones and dendrites were positioned at different depths within the outer medulla. At mid-pupal development L3 growth cones and Tm9 dendrites did not overlap within the column, with most of the growth cones innervating developing layers in the distal medulla (M1-M2) while Tm9 dendrites innervated the developing M3 layer normally ([Figure 8H--H"](#fig8){ref-type="fig"}). In adult flies, we found that compared to wild type L3 clones, *dFezf^1^* clones were weakly labeled by an L3-specific GAL4 driver (9--9 GAL4) ([Figure 8I,I"](#fig8){ref-type="fig"}). Despite the weak labeling, we observed that L3 axon terminals and Tm9 dendrites innervated different depths within the neuropil, and the morphologies of Tm9 dendrites in columns containing wild type or *dFezf^1^* L3 neurons were indistinguishable ([Figure 8I--I"](#fig8){ref-type="fig"}). The decreased labeling observed in mutant clones is likely due to a reduction in 9--9 GAL4 activity during pupal development rather than cell death, as *dFezf^1^* L3 neurons in adult flies were strongly labeled with a pan-neuronal driver (i.e. the *brp* locus) (see [Figure 2G--I,L,N](#fig2){ref-type="fig"}). Thus, dFezf may be required to maintain 9--9 GAL4 expression in L3 neurons.

To summarize, in these experiments we did not observe overlap between the axons of *dFezf* null L3 neurons and Tm9 dendrites during development or in adult flies, strongly pointing to disrupted connectivity between these neurons under these conditions. In addition, it is also likely that dFezf is partially required for R8-Tm9 connectivity, as a significant number of R8 axons terminate in layers distal to M3 in the absence of dFezf function ([Figure 7L,M](#fig7){ref-type="fig"}), and R8 axons and Tm9 dendrites are unlikely to overlap in these columns.

Discussion {#s3}
==========

Laminar organization of synaptic connections is a principal feature of nervous system structure. Thus, determining how cells arrange their connections into layered networks is critical for understanding how the nervous system is assembled. Molecules that are necessary for layer specificity in particular neuron types have been identified in different systems. However, molecular strategies that organize the assembly of specific layers have remained elusive. Here, we illuminate a transcriptional mechanism that coordinates different cell types to the same layer in the *Drosophila* visual system (summarized in [Figure 9](#fig9){ref-type="fig"}). Based on our findings and previous studies, we propose that specific layers are built in a stepwise manner through use of transcriptional modules that cell-intrinsically instruct targeting to specific layers, and cell-extrinsically recruit other circuit components. Moreover, based on research in the mammalian nervous system we propose that this represents an evolutionarily conserved strategy for building laminar-specific neural circuits (see below).

![DFezf coordinates the formation of laminar-specific connections.\
(**A**) Early in medulla development, dFezf promotes the targeting of L3 growth cones to the proximal versus distal domain of the outer medulla. DFezf may regulate this step by controlling a program of dpr gene expression. (**B**) L3 growth cones segregate into the developing M3 layer and secrete Netrin, which regulates the attachment of R8 growth cones within the layer. DFezf also regulates this step by activating the expression of *Netrin* in L3 neurons. (**C**) Within the M3 layer, L3 and R8 axons synapse onto Tm9 dendrites. When dFezf function is lost in L3 neurons, L3 and R8 axons innervate inappropriate layers while Tm9 dendrites innervate the M3 layer normally. As a result, connectivity with Tm9 neurons is disrupted.](elife-33962-fig9){#fig9}

DFezf cell-intrinsically instructs axon target specificity {#s3-1}
----------------------------------------------------------

Early in pupal development, lamina neuron axons project into the outer medulla and terminate in two broad domains ([Figure 1C](#fig1){ref-type="fig"}), which later give rise to refined layers ([Figure 1B](#fig1){ref-type="fig"}). These broad domains represent a primitive form of layer organization, and thus determining how they are established is likely to be central to understanding how specific layers are constructed. The targets of lamina neuron axons within broad domains are unknown, and could include synaptic partners, intermediate targets, guidepost cells, and molecules embedded in the extracellular matrix. Our findings demonstrate that dFezf regulates broad domain specificity in L3 neurons, and indicate that this step in development is crucial for L3 laminar specificity, synaptic connectivity, and for the proper assembly of the M3 layer.

We show that dFezf functions in parallel to CadN and Sema-1a in L3 neurons to regulate targeting to the proximal domain of the outer medulla. We envision three models by which proper growth cone position could be achieved through the combined actions of these molecules. (1) In the first model precise growth cone position is achieved by preventing innervation of inappropriate regions. Here, dFezf prevents growth cone termination within the distal domain of the outer medulla, potentially by repressing the expression of cell surface molecules that interact with targets in this region. And CadN and Sema-1a prevent the growth cones from extending beyond the proximal domain, into the serpentine layer and inner medulla. Thus, proper growth targeting is achieved through mechanisms that prevent both superficial and deeper innervation. (2) Alternatively, growth cone position may be controlled though a direct targeting mechanism. In this model, dFezf could promote targeting to the proximal domain of the outer medulla by activating the expression of cell surface genes that interact with targets in this region. In this context, CadN and Sema-1a would then regulate growth cone consolidation within the proximal domain of the outer medulla. (3) And finally, dFezf function could serve to both prevent termination in the distal domain of the outer medulla, and direct targeting to the proximal domain (combination of (1) and (2)).

In the absence of dFezf function, cell surface genes that are normally expressed by L3 neurons are downregulated, and cell surface genes expressed by other lamina neurons become upregulated. Thus, we favor the third model involving both prevention of superficial termination and directed growth cone targeting. We hypothesize that dFezf function serves to (1) activate the expression of cell surface genes that promote interactions with targets in the proximal domain of the outer medulla, and (2) repress the expression of cell surface genes that mediate interactions with targets in the distal domain. DFezf could accomplish this by directly binding the loci of cell surface genes to control their expression, by acting through intermediate factors, or a combination of both. *Dpr* genes are prominent dFezf targets, and one interesting possibility is that dFezf regulates growth cone targeting by controlling a program of *dpr* gene expression. Dprs that are activated by dFezf function in L3 neurons may mediate interactions with DIP-expressing synaptic targets in the proximal domain of the outer medulla. In contrast, dprs that become upregulated in *dFezf* mutant L3 neurons may mediate inappropriate interactions with DIP-expressing targets in the distal domain of the outer medulla.

Future studies will be dedicated to determining which dFezf target genes regulate L3 growth cone targeting, and the mechanisms by which dFezf regulates their expression. Since, in addition to *dprs*, many cell surface genes change in their levels of expression in the absence of dFezf function, RNA-seq analyses performed at earlier stages of development and in dFezf mis-expression experiments (e.g. in L2 neurons) may help narrow down the list of relevant target genes. In addition, to circumvent issues of functional redundancy it will be important to undertake combinatorial genetic approaches targeting similar genes (e.g. the *dprs*) in loss and gain of function experiments. That a number of transcriptional regulators are differentially expressed between wild type and *dFezf* mutant L3 neurons ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}) suggests that dFezf, at least in part, acts through intermediate regulators to control gene expression. Identification of direct dFezf targets will provide a way of testing this and addressing how dFezf controls gene expression in L3 neurons.

DFezf regulates layer innervation through a cell-extrinsic mechanism {#s3-2}
--------------------------------------------------------------------

Our genetic investigation of dFezf function in L3 neurons revealed a cell-extrinsic role for dFezf in regulating R8 layer specificity through the activation of *NetA/B*. Whether these genes are direct or indirect dFezf targets remains unclear. Preliminary bioinformatics analyses did not identify dFezf binding motifs within the *NetA/B* loci. However, additional experiments are necessary to rigorously assess this, and determine how *NetA/B* expression is controlled in L3 neurons.

Many different neurons have been shown to form synapses within the M3 layer ([@bib37]; [@bib39]), and whether L3-derived Netrin is necessary for the M3-specific innervation of neurons other than R8 remains an open question. The Netrin receptor Frazzled is broadly expressed in the medulla ([@bib42]), and Netrin released from L3 growth cones is well-suited to serve as an M3-specific signal to other cell types, due to its concentration within the layer. Genetic studies disrupting dFezf function and assessing the morphologies of neurons that innervate M3 would provide a way of testing whether L3-derived Netrin broadly organizes M3 circuitry, or specifically controls R8 layer innervation.

In the absence of *dFezf* function in L3 we observed R8 axons inappropriately innervating distal layers (i.e. M0-M2), as expected in the absence of Netrin function ([@bib1]; [@bib42]), and a significant fraction of R8 axons terminating in proximal outer medulla layers (M4-M6), which was unexpected. In vivo time lapse imaging studies showed that the axons of *Frazzled* (Netrin receptor) null R8 neurons targeted to M3 normally and then retracted, indicating that Netrin/Frazzled signaling is required for growth cone stabilization *within* the target layer, but is dispensable for recognition *of* the target layer ([@bib1]). Thus, additional molecules regulate R8 layer specificity. One interesting possibility is that in addition to *Netrin*, dFezf regulates the expression of a gene(s) important for R8 axons to 'recognize' the M3 layer, and in the absence of this cue a subset of R8 axons overshoot M3 and innervate proximal layers. Consistent with this idea, the genetic ablation of L3 neurons caused a significant percentage of R8 axons to terminate in proximal outer medulla layers ([@bib25]). In addition to *Net-A*/*B*, dozens of cell surface or secreted genes are downregulated in L3 neurons at 40 hr APF when *dFezf* is disrupted. Thus, there are a number of candidates that could act downstream of dFezf in parallel to Netrin to regulate R8 layer specificity. Disrupting these genes in L3 neurons and visualizing R8 axons would provide a way of identifying additional L3-derived cues necessary for R8 layer innervation.

A transcriptional mechanism for controlling the stepwise formation of layer-specific circuits {#s3-3}
---------------------------------------------------------------------------------------------

Previous studies indicate that medulla layers are not pre-established regions that serve as a template for circuit formation, but rather that layers are built over time from broad domains as the neurites of different cell types are added in a precise order. Thus, central to elucidating the molecular and cellular logic underlying assembly of the medulla network is identifying the molecular and cellular components involved in the sequence of interactions giving rise to specific layers, and discovering commonalities or connections between interactions and how different layers are assembled. Insight into the cellular mechanisms giving rise to the M3 layer circuitry was provided by the discovery that R8 innervation of M3 relies on a signal from L3 axons (Netrin) ([@bib25]; [@bib42]), which innervate M3 at an earlier stage despite being born later in development ([@bib34]). These studies and the fact that L3 and R8 neurons contribute input to common pathways suggest that the cellular mechanisms governing circuit formation reflect functional relationships between neurons, rather than birth order.

Less progress has been made in identifying the molecular logic underlying the stepwise assembly of layer-specific circuits. This is likely due in part, to the fact that how neurons innervate particular layers is cell type-specific, rather than layer-specific. For example, while R8 neurons depend on Netrin for layer specificity, Netrin is dispensable for the layer innervation of L3 and Tm9 neurons (unpublished results). Thus, identifying commonalities in the mechanisms used by neurons to innervate layers has been challenging. However, here we show that L3 and R8 layer innervation is linked through dFezf, which controls a program of gene expression that regulates the layer innervation of both neurons. Thus, while L3 and R8 utilize different molecules to achieve layer specificity, the expression of key molecules required by each neuron is controlled by the same transcription factor.

Using the same transcriptional pathway or module, to control genes that function cell-intrinsically and cell-extrinsically to regulate layer innervation, represents a simple mechanism for controlling the series of interactions that lead to circuit formation. Employing specific transcriptional modules in specific neurons would ensure that those neurons innervate the correct target layer, and also express the genes necessary for the targeting of other circuit components. We hypothesize that this strategy is widely employed to regulate the assembly of circuitry within the medulla. For example, cell-specific transcription factors analogous to dFezf in L3 have been identified in each of the other lamina neuron subtypes ([@bib40]), and the positions of lamina neuron arborizations in the medulla are well suited to produce signals that regulate the precise layer innervation of other cell types ([Figure 1B](#fig1){ref-type="fig"}). Indeed, CadN-based interactions between L2 terminals and L5 axons are necessary for L5 branching within the M2 layer ([@bib24]). Thus, we hypothesize that the function of cell-specific transcriptional modules in lamina neurons coordinates the assembly of discrete outer medulla layers.

We also speculate that the function of dFezf in L3 neurons is conserved in laminated regions of the mammalian nervous system. For instance, in the inner plexiform layer of the mouse retina, which is analogous to the medulla in structure and function ([@bib31]), Fezf1 is expressed in a subset of bipolar cells that innervate specific sublaminae (i.e. layers) ([@bib36]). Bipolar cells are analogous to lamina neurons, and we hypothesize that Fezf1 in specific types of bipolar cells functions analogously to dFezf in L3 to coordinate laminar-specific connectivity.

In the cerebral cortex of mice, Fezf2 cell-intrinsically controls the identity of subcortically projecting pyramidal neurons that predominantly reside in layer V ([@bib4]; [@bib5]; [@bib21]), and pyramidal neuron identity was shown to be important for the laminar positioning of specific classes of GABAergic neurons ([@bib18]). While it remains unclear as to whether Fezf2 in pyramidal cells regulates the expression of molecules that act non-autonomously to recruit specific inhibitory neurons (analogous to Netrin), one interesting possibility is that Fezf2 in the cortex organizes laminar-specific circuitry through cell-intrinsic and cell-extrinsic mechanisms similar to dFezf in the medulla. In conclusion, we expect our findings regarding the function of dFezf in the *Drosophila* visual system reflect an evolutionarily shared strategy for assembling laminar-specific neural circuits.

Materials and methods {#s4}
=====================

  Reagent type (species)               Designation                                        Source or reference                    Identifiers                                                                     Add. info.
  ------------------------------------ -------------------------------------------------- -------------------------------------- ------------------------------------------------------------------------------- --------------------------------------------------------------------------------------
  Strain (*Drosophila melanogaster*)   9--9 GAL4                                          Gift from U. Heberlein ([@bib24])      N/A                                                                             
  Strain (*D. melanogaster*)           P{10XUAS-IVS-myr::GFP}attP2                        Bloomington Drosophila Stock Center    RRID:[BDSC_32197](https://scicrunch.org/resolver/BDSC_32197)                    
  Strain (*D. melanogaster*)           P{tubP-GAL80}LL10 P{neoFRT}40A                     Bloomington Drosophila Stock Center    RRID:[BDSC_5192](https://scicrunch.org/resolver/BDSC_5192)                      
  Strain (*D. melanogaster*)           P{R27G05-FLPG5.PEST}attP40                         Bloomington Drosophila Stock Center    RRID:[BDSC_55765](https://scicrunch.org/resolver/BDSC_55765)                    
  Strain (*D. melanogaster*)           {LexAop-myr::tdTomato} su(Hw)attP5                 S.L. Zipursky ([@bib6])                N/A                                                                             
  Strain (*D. melanogaster*)           P{20XUAS-RSR.PEST}attP2                            Bloomington Drosophila Stock Center    RRID:[BDSC_55795](https://scicrunch.org/resolver/BDSC_55795)                    
  Strain (*D. melanogaster*)           79C23S-GS-RSRT-STOP-RSRT-smFP_V5-2A-LexA           this paper                             N/A                                                                             See details in 'Construction of transgenic animals' session in Materials and methods
  Strain (*D. melanogaster*)           dFezf2                                             C.Y. Lee ([@bib46])                    N/A                                                                             
  Strain (*D. melanogaster*)           dFezf1                                             C.Y. Lee ([@bib46])                    N/A                                                                             
  Strain (*D. melanogaster*)           CadN1-2 Δ14                                        T.R. Clandinin ([@bib29])              N/A                                                                             
  Strain (*D. melanogaster*)           Sema-1aP1                                          Bloomington Drosophila Stock Center    RRID:[BDSC_11097](https://scicrunch.org/resolver/BDSC_11097)                    
  Strain (*D. melanogaster*)           P{10XUAS-IVS-myr::GFP}su(Hw)attP8                  Bloomington Drosophila Stock Center    RRID:[BDSC_32196](https://scicrunch.org/resolver/BDSC_32196)                    
  Strain (*D. melanogaster*)           P{GMR16H03-lexA}attP40                             Bloomington Drosophila Stock Center    RRID:[BDSC_52510](https://scicrunch.org/resolver/BDSC_52510)                    
  Strain (*D. melanogaster*)           11--164 GAL4                                       Gift from U. Heberlein ([@bib24])      N/A                                                                             
  Strain (*D. melanogaster*)           UAS-dFezf-3xHA                                     C.Y. Lee ([@bib15])                    N/A                                                                             
  Strain (*D. melanogaster*)           27G05-FLP (X)                                      Janelia Farm Research Campus           N/A                                                                             
  Strain (*D. melanogaster*)           P{10XUAS(FRT.stop)GFP.Myr}su(Hw)attP5              Bloomington Drosophila Stock Center    RRID:[BDSC_55810](https://scicrunch.org/resolver/BDSC_55810)                    
  Strain (*D. melanogaster*)           6--60 GAL4                                         Gift from U. Heberlein ([@bib24])      N/A                                                                             
  Strain (*D. melanogaster*)           P{UAS-Dcr-2.D}1                                    Bloomington Drosophila Stock Center    RRID:[BDSC_24648](https://scicrunch.org/resolver/BDSC_24648)                    
  Strain (*D. melanogaster*)           22E09-LexA                                         Janelia Farm Research Campus           N/A                                                                             
  Strain (*D. melanogaster*)           P{GMR24C08-lexA}attP40                             Bloomington Drosophila Stock Center    RRID:[BDSC_62012](https://scicrunch.org/resolver/BDSC_62012)                    
  Strain (*D. melanogaster*)           P{GMR9B08-GAL4}attP2                               Bloomington Drosophila Stock Center    RRID:[BDSC_41369](https://scicrunch.org/resolver/BDSC_41369)                    
  Strain (*D. melanogaster*)           P{TRiP.JF02342}attP2                               Bloomington Drosophila Stock Center    RRID:[BDSC_26778](https://scicrunch.org/resolver/BDSC_26778)                    
  Strain (*D. melanogaster*)           P{20XUAS-RSR.PEST}attP2                            Bloomington Drosophila Stock Center    RRID:[BDSC_55795](https://scicrunch.org/resolver/BDSC_55795)                    
  Strain (*D. melanogaster*)           18B02-dFezf-C1-3xFLAG                              this paper                             N/A                                                                             See details in 'Construction of transgenic animals' session in Materials and methods
  Strain (*D. melanogaster*)           UAS-H2A-GFP                                        S.L. Zipursky ([@bib40])               N/A                                                                             
  Strain (*D. melanogaster*)           P{Rh6-EGFP.P}2                                     Bloomington Drosophila Stock Center    RRID:[BDSC_7461](https://scicrunch.org/resolver/BDSC_7461)                      
  Strain (*D. melanogaster*)           NetBCPTI-000168                                    Kyoto Stock Center                     RRID:[DGGR_115011](https://scicrunch.org/resolver/DGGR_115011)                  
  Strain (*D. melanogaster*)           18B02-dFezf                                        this paper                             N/A                                                                             See details in 'Construction of transgenic animals' session in Materials and methods
  Strain (*D. melanogaster*)           Mi{PT-GFSTF.1}dpr17\[MI08707-GFSTF.1\]             Bloomington Drosophila Stock Center    RRID:[BDSC_61801](https://scicrunch.org/resolver/BDSC_61801)                    
  Strain (*D. melanogaster*)           Mi{PT-GFSTF.1}nrm\[MI01630-GFSTF.1\]               Bloomington Drosophila Stock Center    RRID:[BDSC_60505](https://scicrunch.org/resolver/BDSC_60505)                    
  Strain (*D. melanogaster*)           Mi{PT-GFSTF.0}beat-IIb\[MI03102-GFSTF.0\]          Bloomington Drosophila Stock Center    RRID:[BDSC_59406](https://scicrunch.org/resolver/BDSC_59406)                    
  Strain (*D. melanogaster*)           Mi{PT-GFSTF.1}CG34113\[MI01139-GFSTF.1\]           Bloomington Drosophila Stock Center    RRID:[BDSC_60162](https://scicrunch.org/resolver/BDSC_60162)                    
  Strain (*D. melanogaster*)           PBac{GMR39D12-lexA}VK00027                         Bloomington Drosophila Stock Center    RRID_BDSC_52681                                                                 
  Antibody                             anti-GFP (chicken)                                 Abcam                                  Cat\# ab13970; RRID:[AB_300798](https://scicrunch.org/resolver/AB_300798)       1:1000
  Antibody                             anti-HA (mouse)                                    Abcam                                  Cat\# ab1424; RRID:[AB_301017](https://scicrunch.org/resolver/AB_301017)        1:1000
  Antibody                             anti-V5 (mouse)                                    Bio-Rad/AbD Serotec                    Cat\# MCA2892GA; RRID:[AB_1658039](https://scicrunch.org/resolver/AB_1658039)   1:200
  Antibody                             anti-HA (rabbit)                                   Cell Signaling Technologies            Cat\# 3724S; RRID:[AB_1549585](https://scicrunch.org/resolver/AB_1549585)       1:1000
  Antibody                             anti-DsRed (rabbit)                                Clontech Laboratories, Inc.            Cat\# 632496; RRID:[AB_10013483](https://scicrunch.org/resolver/AB_10013483)    1:200
  Antibody                             anti-chaoptin (mouse)                              Developmental Studies Hybridoma Bank   Cat\# 24B10; RRID:[AB_528161](https://scicrunch.org/resolver/AB_528161)         1:20
  Antibody                             anti-elav (rat)                                    Developmental Studies Hybridoma Bank   Cat\# 7E8A10; RRID:[AB_528218](https://scicrunch.org/resolver/AB_528218)        1:200
  Antibody                             anti-CadN (rat)                                    Developmental Studies Hybridoma Bank   Cat\# DN-Ex 8; RRID:[AB_528121](https://scicrunch.org/resolver/AB_528121)       1:20
  Antibody                             anti-FLAG (mouse)                                  Sigma-Aldrich                          Cat\# F1804; RRID:[AB_262044](https://scicrunch.org/resolver/AB_262044)         1:1000
  Antibody                             Goat anti-chicken IgG (H + L) Alexa Fluor 488      Thermo Fisher Scientific               Cat\# A-11039; RRID:[AB_142924](https://scicrunch.org/resolver/AB_142924)       1:500
  Antibody                             Goat anti-rabbit IgG (H + L) Alexa Fluor 568       Thermo Fisher Scientific               Cat\# A-11011; RRID:[AB_143157](https://scicrunch.org/resolver/AB_143157)       1:500
  Antibody                             Goat anti-mouse IgG (H + L) Alexa Fluor 647        Thermo Fisher Scientific               Cat\# A-21236; RRID:[AB_141725](https://scicrunch.org/resolver/AB_141725)       1:500
  Antibody                             Goat anti-mouse IgG1 Alexa Fluor 568               Thermo Fisher Scientific               Cat\# A-21124; RRID:[AB_2535766](https://scicrunch.org/resolver/AB_2535766)     1:500
  Antibody                             Goat anti-guinea pig IgG (H + L) Alexa Fluor 568   Thermo Fisher Scientific               Cat\# A-11075; RRID:[AB_2534119](https://scicrunch.org/resolver/AB_2534119)     1:500
  Antibody                             Goat anti-Rat IgG (H + L) Alexa Fluor 647          Thermo Fisher Scientific               Cat\# A-21247; RRID:[AB_141778](https://scicrunch.org/resolver/AB_141778)       1:500
  Antibody                             anti-dFezf (rabbit)                                C. Y. Lee (Janssens et al., 2014)      RRID:[AB_2568138](https://scicrunch.org/resolver/AB_2568138)                    1:50
  Antibody                             anti-svp (mouse)                                   Developmental Studies Hybridoma Bank   RRID:[AB_2618079](https://scicrunch.org/resolver/AB_2618079)                    1:10
  Antibody                             anti-bsh (guinea pig)                              S.L. Zipursky ([@bib11])               RRID:[AB_2567934](https://scicrunch.org/resolver/AB_2567934)                    1:200
  Antibody                             anti-pdm3 (guinea pig)                             J.R. Carlson ([@bib41])                RRID:[AB_2569865](https://scicrunch.org/resolver/AB_2569865)                    1:500
  Antibody                             anti-bab1 (rabbit)                                 S.B. Carroll ([@bib47])                RRID:[AB_2570113](https://scicrunch.org/resolver/AB_2570113)                    1:200
  Antibody                             anti-NetB (guinea pig)                             B. Altenhein                           N/A                                                                             1:50
  Commercial assay or kit              Illumina Nextera XT DNA Library Preparation Kit    Illumina                               Cat\# FC-131--1024                                                              
  Commercial assay or kit              Illumina Nextera XT Index Kit                      Illumina                               Cat\# FC-131--1001                                                              

Full genotypes of flies in each experiment {#s4-1}
------------------------------------------

Relevant figuresAbbreviated namesGenotypes[Figure 2](#fig2){ref-type="fig"}A-Dw;;9--9 GAL4, UAS-myr::GFPE, F, K, Mwtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A, LexAop-myr::tdTomato; 9--9 GAL4, UAS-R/79C23S-GS-RSRT-STOP-RSRT-smFP_V5-2A-LexAG, H, I, L, N, O, P, Q,dFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/ dFezf^1^, FRT40A, LexAop-myr::tdTomato;9--9 GAL4, UAS-R/79C23S-GS-RSRT-STOP-RSRT-smFP_V5-2A-LexA[Figure 3](#fig3){ref-type="fig"}A, B, F, G, Nwtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A; 9--9 GAL4, UAS-myr::GFPC, D, H, I, J, OdFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/ dFezf^1^, FRT40A; 9--9 GAL4, UAS-myr::GFPMdFezf^1^ + BACw; Tub-GAL80, FRT40, 27G05-FLP::PEST/ dFezf^1^, FRT40; 9--9 GAL4, UAS-myr::GFP/18B02-dFezf (BAC)PCadN, Sema-1a, dFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/CadN1-2 Δ14, Sema-1a P1, dFezf^1^, FRT40A; 9--9 GAL4, UAS-myr::GFPQCadN, Sema-1aw; tubP-GAL80, FRT40A, 27G05-FLP/CadN1-2 Δ14, Sema-1a P1, FRT40A;9--9 GAL4, UAS-myr::GFP[Figure 4](#fig4){ref-type="fig"}A, Cmis-exp27G05-FLP; UAS-FRT-STOP-FRT-myr::GFP;6--60 GAL4/UAS-dFezf-3xHABwt27G05-FLP; UAS-FRT-STOP-FRT-myr::GFP;6--60 GAL4E-E\'\'\', G, Imis-expUAS-myr::GFP; tubP-GAL80, FRT40A, 27G05-FLP/16H03-LexA, FRT40A, LexAop-myr::tdTomato; 11--164 GAL4/UAS-dFezf-3xHAF, HwtUAS-myr::GFP; tubP-GAL80, FRT40A, 27G05-FLP/16H03-LexA, FRT40A, LexAop-myr::tdTomato; 11--164 GAL4[Figure 5](#fig5){ref-type="fig"}A, B, C, Dw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A (FRT40A, *dFezf1*); 9--9 GAL4, UAS-myr::tdTomato/UAS-H2A-GFP[Figure 6](#fig6){ref-type="fig"}A, B, ENetB^CPTI-000168^/w(Y); Bl/CyO-GFP; 18B02-dFezf-C1-3xFLAG (BAC)/TM2(TM6B)CNetB^CPTI-000168^/w(Y); FRT40, LexAop-myr::tdTomato/Bl; 31C06-LexA, UAS-dFezf-HA/TM6BD, D\'NetB^CPTI-000168^/w(Y); 16H03-LexA, LexAop-myr::tdTomato/Bl(CyO-GFP); TM2/TM6BFNetB^CPTI-000168^/w(Y); FRT40, LexAop-myr::tdTomato/Bl; 31C06-LexA, UAS-dFezf-HA/TM6BG, HNetB^CPTI-000168^/w; Bl/Sco; UAS-dFezf-HA/TM6B[Figure 7](#fig7){ref-type="fig"}A, A\'wtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A, LexAop-myr::tdTomato; 9--9 GAL4, UAS-R/79C23S-G5-RSRT-STOP-RSRT-SmGFP10xV5-2A-LexAB, B\'dFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/ dFezf^1^, FRT40A, LexAop-myr::tdTomato;9--9 GAL4, UAS-R/79C23S-G5-RSRT-STOP-RSRT-SmGFP10xV5-2A-LexAC, EcontrolUAS-Dcr2 (w)/yv (w, or Y); 22E09-LexA, LexAop-myr::tdTomato/+; TM6B/UAS-dFezf RNAi (BDSC 26778)D, FdFezf RNAiUAS-Dcr2 (w)/yv (w, or Y); 22E09-LexA, LexAop-myr::tdTomato/+; 9B08-GAL4 (TM6B)/UAS-dFezf RNAi (BDSC 26778)G, IcontrolNetB^CPTI-000168^/w; Bl/Sco; UAS-dFezf-HA/TM6BH, Jmis-expressionNetB^CPTI-000168^/w; Bl/Sco; UAS-dFezf-HA/11--164 GAL4KcontrolUAS-Dcr2/yv (w, or Y); Rh6-EGFP/22E09-LexA, LexAop-myr::tdTomato; UAS-dFezf RNAi (BDSC 26778) (TM6B)/9B08-GAL4 (TM2)LdFezf RNAiUAS-Dcr2/yv (w, or Y); Rh6-EGFP/22E09-LexA, LexAop-myr::tdTomato; UAS-dFezf RNAi (BDSC 26778)/9B08-GAL4[Figure 8](#fig8){ref-type="fig"}A-B\'\', C, D-D', E-E\'\', F-F'wtw/w(Y); FRT40/Tub-GAL80, 27G05-Flp, FRT40; 9--9 GAL4, UAS-R/24C08-LexA, LexAop-myr::td-TomatoG-G', H-H', I-I'dFezf^1^\
dFezf2w/w(Y); dFezf^1^ (dFezf^2^), FRT40/Tub-GAL80, 27G05-FLP, FRT40; 9--9 GAL4, UAS-R/24C08-LexA, LexAop-myr::td-Tomato[Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}A-CdFezf^2^w; Tub-GAL80, FRT40, 27G05-FLP::PEST/ dFezf^2^, FRT40; 9--9 GAL4, UAS-myr::GFP/TM2(TM6B)[Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}A, C,dFezf^1^ + BACw; Tub-GAL80, FRT40, 27G05-FLP::PEST/ dFezf^1^, FRT40; 9--9 GAL4, UAS-myr::GFP/18B02-dFezf (BAC)EdFezf^2^ + BACw; Tub-GAL80, FRT40, 27G05-FLP::PEST/ dFezf^2^, FRT40; 9--9 GAL4, UAS-myr::GFP/18B02-dFezf (BAC)[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}AdFezf mis-exp (24 hr APF)27G05-FLP; UAS-FRT-STOP-FRT-myr::GFP;6--60 GAL4/UAS-dFezf-3xHAB and DwtUAS-myr::GFP/27G05-FLP(attp18); tub-GAL80, FRT40A/FRT40A, LexAop-myr::tdTomato; 11--164 GAL4/39D12-LexAC and Dmis-expUAS-myr::GFP/27G05-FLP(attp18); tub-GAL80, FRT40A/FRT40A, LexAop-myr::tdTomato; 11--164 GAL4/39D12-LexA, UAS-dFezf-3xHA[Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}A, A\'wtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.1}dpr17\[MI08707-GFSTF.1\]B, B\'dFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/dFezf1, FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.1}dpr17\[MI08707-GFSTF.1\]C, C\'wtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.1}nrm\[MI01630-GFSTF.1\]D, D\'dFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/dFezf1, FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.1}nrm\[MI01630-GFSTF.1\]E, E\'wtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.0}beat-IIb\[MI03102-GFSTF.0\]F, F'dFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/dFezf1, FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.0}beat-IIb\[MI03102-GFSTF.0\]G, G'wtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.1}CG34113\[MI01139-GFSTF.1\]H, H'dFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/dFezf1, FRT40A;9--9 GAL4, UAS-myr::tdTomato/Mi{PT-GFSTF.1}CG34113\[MI01139-GFSTF.1\][Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}A, Bwt\
w; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A; 9-9-GAL4,\
UAS-myr::tdTomato/UAS-H2A-GFPA, BdFezf^1^w; tubP-GAL80, FRT40A, 27G05-FLP/dFezf1, FRT40A;\
\
9-9-GAL4, UAS-myr::tdTomato/UAS-H2A-GFP\
\
CCadN, Sema-1aw; tubP-GAL80, FRT40A, 27G05-FLP/CadN1-2 Δ14,\
Sema-1a P1, FRT40A, LexAop-myr::tdTomato;\
\
9-9-GAL4, UAS-R/79C23S-GS-RSRT-STOP-RSRT-smFP_V5-2A-LexACwtw; tubP-GAL80, FRT40A, 27G05-FLP/FRT40A,\
\
LexAop-myr::tdTomato; 9-9-GAL4,\
UAS-R/79C23S-GS-RSRT-STOP-RSRT-smFP_V5-2A-LexACdFezf^1^w; tubP-GAL80, FRT40A,\
\
27G05-FLP/dFezf1, FRT40A, LexAop-myr::tdTomato;\
\
9-9-GAL4, UAS-R/79C23S-GS-RSRT-STOP-RSRT-smFP_V5-2A-LexA[Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}A, Bw; Bl/CyO-GFP; 18B02-dFezf-C1-3xFLAG (BAC)/TM6B

Experimental model and subject details {#s4-2}
--------------------------------------

### Description of replicates {#s4-2-1}

In general, the replicates for each experiment are indicated by the number of cells and brains examined (denoted in the figures and figure legends). There are essentially three types of replicates we consider. Within each optic lobe, each column is replicated hundreds of times, different lobes of the same brain are replicates, and the lobes of different brains are also replicates. In all experiments, the phenotypes reported are consistently reproducible for each type of replicate considered (i.e. within and between different animals)

### Fly strains {#s4-2-2}

Flies were raised on standard cornmeal-agar based medium. Male and females flies were used at the following development stages: 3^rd^ instar, 12 hr after pupariam formation (h APF), 24 hr APF, 48 hr APF, 72 hr APF and newly eclosed adults (within 5 hr of eclosion).

The following strains were obtained from Bloomington Stock Center (Indiana University):

10xUAS-IVS-myr::GFP \[attp2\], tubP-GAL80, FRT40A, R27G05-FLPG5.PEST \[attP40\], 20XUAS-RSR.PEST \[attP2\], 10XUAS-IVS-myr::GFP \[su(Hw)attP8\], GMR16H03-lexA \[attP40\], 10xUAS-FRT-stop-FRT-myr::GFP \[su(Hw)attP5\], UAS-Dcr-2, GMR24C08-lexA \[attP40\], GMR9B08-GAL4 \[attP2\], TRiP.JF02342 \[attP2\] (dFezf RNAi), 20xUAS-RSR.PEST \[attP2\], Rh6-EGFP

The following strains were obtained from Janelia Research Campus:

R27G05-FLPG5.PEST \[attp18\], 22E09-LexA, 39D12-LexA

The following stocks were generated in the Pecot Laboratory for this study:

18B02-dFezf, 18B02-dFezf-C1-3xFLAG

The following strains were gifts from other laboratories:

9--9 GAL4, 6--60 GAL4, 11--164 GAL4 (U. Heberlein), LexAop-myr::tdTomato \[su(Hw)attP5\] (S.L. Zipursky), UAS-dFezf-3xHA, dFezf^1^, dFezf^2^ (C.Y. Lee), CadN1-2 ^Δ14^ (T.R. Clandinin)

Construction of transgenic animals {#s4-3}
----------------------------------

### Generation of the BRP presynaptic marker 79C23S-RSRT-STOP-RSRT-smFPV5-2A-LexA {#s4-3-1}

Restriction free cloning (van den Ent and Löwe 2006) was used to insert smFP_V5 ([@bib44]) (addgene: pCAG_smFPV5 plasmid\# 59758) in between RSR and the 2A peptide (2A) within 'cassette F' (see below), which was made by Chen and colleagues for generation of the original Brp STaR marker ([@bib6]). This replaced the original V5 tag and generated:

Cassette G: GS linker-RSR-STOP-RSR-smFP_V5-2A-LexAVP16

\[Cassette F: GS linker-RSR-STOP-RSR-V5-2A-LexAVP16\]

The modification of the BAC CH321-79C23S ([@bib6]) was performed using the recombineering protocol described previously ([@bib35]).

### Generation of 18B02-dFezf and 18B02-dFezf-C1-3xFLAG {#s4-3-2}

A bacterial artificial chromosome (BAC) (CH321-18B02) containing the dFezf locus was ordered from BACPAC Resources, and inserted into the VK33 genomic site, resulting in the 18B02-dFezf strain.

The modification of the BAC was performed using the recombineering protocol described previously (Sharan et al., 2009, Nature Protocols).

The wild type 18B02 BAC was transformed into the SW102 E. coli strain ([@bib45]). RpsL-Kan cassette with homology arms flanking the first stop codon of the dFezf locus was amplified using the following primers:

Forward: ACCATCAGCAGCAGCAAAGACTCTCGGAGACCTTCATAGCCAAGGTGTTTAGCTTCACGCTGCCGCAAGCACTCAG

Reverse: GAGGTCGACCCCGTGGAGCTGTTCAAGCTTTCCGCATAGTATCGCTGTCAGGGGTGGGCGAAGAACTCCAGCATGA

The PCR product was transformed into the 18B02-harboring SW102 cells, and the RpsL-Kan cassette was inserted before the first stop codon by homologous recombination.

1 kb of DNA fragment centered by the first stop codon of the dFezf locus was PCR amplified from the genomic DNA using the following primers:

Forward: CTCACCTTCCACATGCACAC

Reverse: GCGTGTCTACACGGAACTCA

This fragment was then cloned into pGEM-T vector (Promega, Madison, USA). Using the resulting construct as template, site-directed mutagenesis was performed by PCR using the following primers so that the 3xFLAG sequence was inserted before the first stop codon of the dFezf locus on the plasmid:

Forward: GAGACCTTCATAGCCAAGGTGTTTGACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGATGACGATGACAAGTGACAGCGATACTATGCGGAAAGC

Reverse: CGAGAGTCTTTGCTGCTGCTGATG

Using the resulting construct as the template, PCR was performed using the following primers to amplify the DNA fragment having 3xFLAG inserted before the first stop codon of the dFezf locus and flanked by \~500 bp of homology arms:

Forward: CATCCGCAAAGCCAGCAACA

Reverse: GAGGTGGCCATCGAGGATAT

The PCR product was then transformed into the SW102 cells that harbored modified 18B02 with RpsL-Kan cassette inserted before the first stop codon of the dFezf locus. The RpsL-Kan cassette was then replaced by 3xFLAG by recombination, resulting in a BAC that has 3xFLAG inserted right before the first stop codon of the dFezf locus. The 3xFLAG tagged BAC was inserted into the VK33 genomic site, resulting in the 18B02-dFezf-C1-3xFLAG strain.

Method details {#s4-4}
--------------

### Immunohistochemistry {#s4-4-1}

Fly brains were dissected in Schneider's medium and fixed in 4% paraformaldehyde in phosphate buffered lysine for 25 min. After fixation, brains were quickly washed with phosphate buffer saline (PBS) with 0.5% Triton-X-100 (PBT) and incubated in PBT for at least 2 hr at room temperature. Next, brains were incubated in blocking buffer (10% NGS, 0.5% Triton-X-100 in PBS) overnight at 4°C . Brains were then incubated in primary antibody (diluted in blocking buffer) at 4°C for at least two nights. Following primary antibody incubation, brains were washed with PBT three times, 1 hr per wash. Next, brains were incubated in secondary antibody (diluted in blocking buffer) at 4°C for at least two nights. Following secondary antibody incubation, brains were washed with PBT two times, followed by one wash in PBS, 1 hr per wash. Finally, brains were mounted in SlowFade Gold antifade reagent (Thermo Fisher Scientific, Waltham, MA).

Confocal imaging was accomplished using either a Leica SP8 laser scanning confocal microscope or an Olympus FV1200 Laser Scanning Microscope. Fiji ([@bib32]; [@bib33]) was used to create z stack images.

The primary antibodies used were as follows: anti-GFP (chicken, 1:1000, ab13970) and anti-HA (mouse, 1:1000, ab1424) were purchased from Abcam. Anti-V5 (mouse, 1:200, MCA2892GA) was purchased from Bio-Rad. Anti-HA (rabbit, 1:1000, 3724S) was purchased from Cell Signaling Technologies. Anti-DsRed (rabbit, 1:200, 632496) was purchased from Clontech Laboratories, Inc. Anti-chaoptin (mouse, 1:20, 24B10), anti-elav (rat, 1:200, 7E8A10), anti-CadN (rat, 1:20, DN-Ex 8) and anti-seven-up (mouse, 1:10, 2D3) were purchased from Developmental Studies Hybridoma Bank. Anti-FLAG (mouse, 1:1000, F1804) was purchased from Sigma-Aldrich. Anti-dFezf (rabbit, 1:100) was a gift from C.Y. Lee. Anti-bsh (guinea pig, 1:200) was a gift from S.L. Zipursky. Anti-pdm3 (guinea pig, 1:500) was a gift from J.R. Carlson. Anti-bab1 (rabbit, 1:200) was a gift from S.B. Carroll. Anti-NetB (guinea pig, 1:50) was a gift from B. Altenhein.

The secondary antibodies used were as follows: Goat anti-chicken IgG (H + L) Alexa Fluor 488 (A-11039), Goat anti-rabbit IgG (H + L) Alexa Fluor 568 (A-11011), Goat anti-mouse IgG (H + L) Alexa Fluor 647 (A-21236), Goat anti-mouse IgG1 Alexa Fluor 568 (A-21124), Goat anti-guinea pig IgG (H + L) Alexa Fluor 568 (A-11075), Goat anti-Rat IgG (H + L) Alexa Fluor 647 (A-21247) were all purchased from Thermo Fischer Scientific and were all used at a dilution of 1:500.

### MARCM and MARCM + STaR experiments {#s4-4-2}

In most MARCM experiments, Flp recombinase was expressed in lamina neuron precursor cells using R27G05-FLPG5.PEST (attP40) to induce mitotic recombination, generating single lamina neuron clones, which were visualized using cell-specific GAL4 drivers. To generate sparse lamina neuron clones in L2 mis-expression experiments ([Figure 4---figure supplement 1B-D](#fig4s1){ref-type="fig"}), R27G05-FLPG5.PEST (attp18) was used to induce mitotic recombination.

In experiments utilizing STaR and MARCM Flp recombinase in lamina neuron precursor cells induced mitotic recombination generating a subset of L3 neurons that were homozygous for the control chromosome (FRT40) or *dFezf*^1^. In L3 clones R recombinase was expressed (9--9 GAL4) and induced recombination within the Brp locus in a bacterial artificial chromosome (79C23S) resulting in the incorporation of smFP_V5 at the C-terminus. In addition, this resulted in the co-translation of LexA, which activated the expression of LexAop-myr::tdTomato to visualize the morphology of L3 clones. Together, this allowed visualization of L3 morphology and endogenous pre-synaptic sites with single cell resolution in wild type conditions or when *dFezf* was disrupted, in an otherwise normal fly. smFP_V5 contains ten V5 epitopes built into a superfolding GFP backbone (Viswanathan et al., 2015). We find that it is considerably more sensitive than the original V5 tag in the STaR Brp constructs.

### FlpOut experiments {#s4-4-3}

To generate sparsely labeled L5 neurons, we used an interruption cassette (UAS-FRT-STOP-FRT-myr::GFP) to drive stochastic expression of myr::GFP with an L5 GAL4 driver (6--60 GAL4). Stochastic expression was accomplished through inefficient expression of Flp recombinase in lamina neurons (R27G05-FLP::PEST \[attp18\]). For reasons that are unknown, this Flp source results in stochastic recombination allowing for visualization of single neurons.

### RNA seq experiments {#s4-4-4}

For each genotype (control, *dFezf^1^*) 120 crosses were set, with 15 females and seven males in each cross. After three days, each cross was flipped every day for a week. From those vials we picked out Tb-negative white pre-pupae that formed within a one-hour window and placed the pupae in separate vials. GFP-positive pupae were scored under the fluorescence microscope and removed from the vials. The rest of the pupae were kept at 25°C. After 40 hr, we dissected the staged pupae within an hour in cold Complete Schneider's Medium (CSM: 50 mL of CSM consists of 5 mL of heat inactivated fetal bovin serum, 0.1 mL Insulin, 1 mL PenStrep, 5 mL L-Glutamine, 0.4 mL L-Glutathione and 37.85 mL Schneider's medium, filter setrilized). About 50--100 brains were dissected for each independent replicate experiment. After dissection of the brains, the optic lobes were collected and pooled together in 1x Rinaldini's solution (100 mL Rinaldini's solution consists of 800 mg NaCl, 20 mg KCl, 5 mg NaH~2~PO~4~, 100 mg NaHCO~3~ and 100 mg Glucose in H~2~O, filter setrilized) for subsequent dissociation. We used a modified dissociation protocol based on one described previously ([@bib10]). The pooled lobes were washed once with 500 uL 1x Rinaldini's solution and then incubated at 37°C for 15 min in dissociation solution that consists of 300 uL papain (100 U/mL) and 4.1 uL Liberase at a final concentration of 0.18 Wu/mL. After the enzyme digestion, the lobes were washed twice with 500 uL of 1x Rinaldini's solution and then twice with 500 uL of CSM. The lobes were then disrupted in 200 uL of CSM by pipetting up and down until the solution became homogeneous. The cell suspention was then filtered through a 30 um mesh 5 mL FACS tube, and diluted with another 500 uL of CSM. The FACS sorting was done on the BD FACS Aria with a nozzle size of 70 um. GFP and dsRed double positive cells were sorted directly into 300 uL of RLT buffer (Qiagen, RNeasy kit) containing 1:100 beta-mercaptoethanol. Total RNA was purified with Qiagen RNeasy kit and eluted in 15 uL of water. After all the samples from five replicates (each genotype) were available, we concentrated the RNA into 5 uL by speed vac. 1.5 uL of the concentrated RNA was used to make cDNA library by Smart-seq2 as previously described ([@bib28]). The quality control of the libraries was done on the Bioanalyzer by Tapestation. The pooled libraries were then loaded onto a single flow cell and sequenced by NextSeq High Output. Between five and fourteen million mapped reads were obtained for each sample.

Quantification and statistical analyses {#s4-5}
---------------------------------------

### General {#s4-5-1}

The quantification for immunohistochemistry experiments can be found either within the figure or in the figure legend. In all cases, N refers to the number of cells scored.

### Analysis of RNA seq data {#s4-5-2}

The quality of the sequencing files was initially assessed with the FastQC tool. They were then trimmed to remove contaminant sequences (like polyA tails), adapters and low-quality sequences with cutadapt. These trimmed reads were aligned to the drosophila genome (Flybase relase dmel_r6.15_FB2017_02) using STAR aligner. Alignments were checked using a combination of FastQC, Qualimap, MultiQC and custom tools. Counts of reads aligning to known genes were generated by featureCounts. In parallel, Transcripts Per Million (TPM) measurements per isoform were generated using Salmon. Differential expression at the gene level was called with DESeq2. We used the counts per gene estimated from the Salmon by tximport as input to DESeq2 as quantitating at the isoform level has been shown to produce more accurate results at the gene level. As described in the DESeq2 documentation, the differential expression is assessed using a Wald Test and p-values are adjusted for multiple testing using Benjamini-Hochberg FDR correction.
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Luo

Liqun
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Howard Hughes Medical Institute, Stanford University

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"*Drosophila* Fezf coordinates laminar-specific connectivity through cell-intrinsic and cell-extrinsic mechanisms\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and K VijayRaghavan as the Senior Editor. The reviewers have opted to remain anonymous.

As you see, reviewers complimented the technical quality of the study, but were split in their assessment whether the advance is sufficient for *eLife*. After extensive discussions, we are writing to invite you for a revision that shall address reviewers\' critiques as thoroughly as possible. In particular, all reviewers agreed that a full description of the RNA-seq data and thorough analysis, hopefully with more insights, are required for the revised manuscript to cross the threshold of advance for an *eLife* paper.

Summary:

Neural circuits both in vertebrates and invertebrates are frequently arranged in a layered organization, essential for correct function of these circuits. However, identifying the molecules involved in the precise building of this laminar arrangement, and in the formation of layer-specific connections has been a long-standing question in the field. The present work by Santiago and colleagues furthers our understanding of neuropil targeting and neural circuit formation in the medulla of the *Drosophila* optic lobe. Building on previous results and the data presented in this manuscript, the authors show that layer targeting of two different neurons, lamina neuron L3 and photoreceptor R8, is controlled by the *Drosophila* ortholog of the transcription factors Fezf, genes that play an important role in cortical patterning in mammals. dFezf instructs L3 layer targeting specificity from early pupal stages, being necessary both for broad domain specificity and for final M3 layer targeting specificity. Using RNA-seq and genetic approaches, the authors found that dFezf is cell autonomously required for Netrin expression in L3 neurons.

Importantly, the authors determined that the expression of this transcription factor in L3 neurons is required for correct R8 layer targeting, likely through the activation of Netrin expression in L3 neurons. The authors propose that transcription factors modules regulating layer targeting by acting into different neurons can be a common mechanism of neural circuit formation.

Since Fezf controls the expression of Netrin in L3 neurons and Netrin provided by L3 has been shown to be important for R8 growth cone stabilization in the M3 layer (Akin and Zipursky, 2016), the authors assume that Fezf is controlling R8 targeting through Netrin expression in L3 neurons. However, they also point out that Fezf in L3 neurons could be controlling the expression of additional molecules involved in R8 targeting/recognition. They do not go into detail about the possible molecules/mechanisms.

Our editorial discussions raised some important general concerns which need to be addressed. An expectation, perhaps high, from this study was an evaluation of layered connectivity that goes beyond a single pair of neurons that target one particular layer. In addition, some insight into the genetic program that FezF regulates to control L3 targeting also seems important. There are many examples of ligand receptor systems that control layered targeting, and in many cases, prior studies have gone well beyond a description of the anatomy to evaluate the importance of layer-specific targeting for the control of the physiological properties of the connected neurons. The current paper can also go beyond what is appears a limited scope if the following essential revisions are squarely addressed.

Essential revisions:

The paper is well written and all the figures clearly represent the findings. While we are positive about the quality of this work its significance could be made much more compelling if the complete results of the RNA-seq were included in the paper. This would be simplest. Alternatively other methods should be used to document changes in the expression of relevant transcripts.

The question remains, which molecules downstream of dFezf are involved in L3 layer targeting. It is interesting that the authors did not find candidate molecules in the RNA-seq experiments performed at 40h APF, given that it is an important developmental stage for L3 layer targeting. The authors should provide the results of the screen and comment on what they find in the Discussion. (Also, this question could be better addressed with similar RNA-seq experiments performed at different stages throughout development, although this would be outside of the scope of this paper). Specifically, also see subsection "DFezf functions in parallel to CadN and Sema-1a to regulate L3 growth cone targeting": the single-cell type RNA-seq analysis for L3 neurons is elegantly performed. While, this is technically attractive, yet very limited data are presented in the manuscript.

Subsection "DFezf acts instructively to regulate growth cone targeting to the proximal domain of the outer medulla": When authors describe the instructive role of Fezf, authors firstly expressed Fezf only in L5, which did not exhibit defects in L5 neurons (innervation to the proximal domains). On the other hand, authors expressed Fezf in all the lamina neurons (pan-lamina neuron GAL4 driver, 11-164-GAL4) and independently labeled L2 neurons, which exhibited mis-innervation defects. These experiments do not directly indicate the instructive role of Fezf for M3 layer innervation. It is still possible that the forced Fezf expression in the lamina neurons except L2 neurons indirectly affect L2 neuron innervation. Authors should explain this possibility. In addition, it is better to express Fezf only in L2 neuron to check the instructive role of Fezf for M3 layer innervation.

Also, in subsection "DFezf is necessary and sufficient for Netrin expression": Authors described that forced expression of Fezf in L2 neurons is sufficient to induce Net-B expression without showing any images. It is better to present some images or graphs to explain this result.

The authors show that L3 terminal mis-targeting is associated with changes in the localization of presynaptic Brp puncta ([Figure 2K, L](#fig2){ref-type="fig"}), suggesting that dFezf mutant L3 neurons have defects not only in layer innervation but in synaptic partner matching. However, this analysis leaves several questions unresolved that would aid in interpreting the results. Are there quantifiable differences in the number of Brp puncta that are associated with dFezf mutant L3 neurons compared to wild type clones? Also, is there additional evidence that would support the conclusion that L3 presynaptic sites in dFezf mutants represent functioning synapses formed with ectopic partners?

The model strongly predicts that the FezF gain of function phenotypes should depend on induction of Netrin expression and thus should be suppressed in a Netrin mutant background. Is this the case?

As the core of this paper is the function of Fezf, authors should present how Fezf works as \"a transcription factor\" in M3 layer innervation. For instance, whether can Fezf directly bind to the enhancer of Net-B gene? Which gene (gene set) expression is regulated by Fezf (probably RNA-seq data)? Alternatively, other evidence is also okay, but we suggest that the authors provide and discuss the mechanism how Fezf is involved in M3 layer targeting in more detail.

10.7554/eLife.33962.028

Author response

> Essential revisions:
>
> The paper is well written and all the figures clearly represent the findings. While we are positive about the quality of this work its significance could be made much more compelling if the complete results of the RNA-seq were included in the paper. This would be simplest. Alternatively other methods should be used to document changes in the expression of relevant transcripts.

We have included the entire RNA-seq data set in the revised version of the paper, and a detailed analysis of the data, which includes discussion of potential dFezf targets that regulate growth cone targeting in the main text and Discussion sections. The data are presented in several new figures. In general, many genes change in their levels of expression in the absence of dFezf function (455 differentially expressed genes). Similar fractions of genes are either up or downregulated, indicating that dFezf function acts to repress or activate gene expression, directly or through intermediate factors (\~20 TFs are differentially expressed). Members of the dpr gene family are prominent targets (the top three most significant genes are dprs). We propose a model wherein dFezf regulates growth cone targeting by controlling a program of dpr gene expression. However, given the complexity of the dFezf gene program, addressing which genes regulate growth cone targeting and how dFezf regulates their expression will require considerable effort and further analyses. This was one of the reasons behind our hesitation for including the data.

[Figure 5](#fig5){ref-type="fig"} demonstrates the efficacy of L3 purification from MARCM experiments using FACS, shows a heat map of all differentially expressed genes and their expression levels in all samples, and also includes a table of differentially expressed dpr genes (11 in total).

In the Materials and methods section (Quantification and statistical analyses: Analysis of RNA seq data), we have included a link to an HTML document containing all quality control and differential gene expression analyses performed on the RNA-seq data.

[Supplementary file 1](#supp1){ref-type="supplementary-material"} is an excel file containing normalized transcript values for all genes across all samples (regardless of significance).

[Supplementary file 2](#supp2){ref-type="supplementary-material"} is an excel file containing information regarding differentially expressed genes: gene name, bio categories, gene family information, normalized transcript values across all samples, fold change, and p-values.

[Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} shows validation of changes in mRNA expression for 4 genes at the protein level.

[Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} shows the distribution of differentially expressed genes in specific biological categories. This shows that more than 100 DE genes are cell surface and secreted molecules.

Discussion of the RNA-seq data has been included in the section titled: "DFezf regulates a complex program of cell surface gene expression".

We also discuss the data in detail in the Discussion, primarily within the section titled "DFezf cell-intrinsically instructs axon target specificity", which has been revised to incorporate the implications of these findings, but also within the section titled **"**DFezf regulates layer innervation through a cell-extrinsic mechanism".

> The question remains, which molecules downstream of dFezf are involved in L3 layer targeting. It is interesting that the authors did not find candidate molecules in the RNA-seq experiments performed at 40h APF, given that it is an important developmental stage for L3 layer targeting. The authors should provide the results of the screen and comment on what they find in the Discussion. (Also, this question could be better addressed with similar RNA-seq experiments performed at different stages throughout development, although this would be outside of the scope of this paper). Specifically, also see subsection "DFezf functions in parallel to CadN and Sema-1a to regulate L3 growth cone targeting": the single-cell type RNA-seq analysis for L3 neurons is elegantly performed. While, this is technically attractive, yet very limited data are presented in the manuscript.

Please see the response to the first essential revision comment above, which we feel also addresses the issues brought up here.

> Subsection "DFezf acts instructively to regulate growth cone targeting to the proximal domain of the outer medulla": When authors describe the instructive role of Fezf, authors firstly expressed Fezf only in L5, which did not exhibit defects in L5 neurons (innervation to the proximal domains). On the other hand, authors expressed Fezf in all the lamina neurons (pan-lamina neuron GAL4 driver, 11-164-GAL4) and independently labeled L2 neurons, which exhibited mis-innervation defects. These experiments do not directly indicate the instructive role of Fezf for M3 layer innervation. It is still possible that the forced Fezf expression in the lamina neurons except L2 neurons indirectly affect L2 neuron innervation. Authors should explain this possibility. In addition, it is better to express Fezf only in L2 neuron to check the instructive role of Fezf for M3 layer innervation.
>
> Also, in subsection "DFezf is necessary and sufficient for Netrin expression": Authors described that forced expression of Fezf in L2 neurons is sufficient to induce Net-B expression without showing any images. It is better to present some images or graphs to explain this result.

We apologize for not clearly describing how the L2 mis-expression experiment was done in the main text. Like the reviewer, we were also concerned about non-autonomous effects of dFezf mis-expression. Since there is not an L2-specific driver that is active in early pupal development (none has been published, and we have thus far not discovered one despite considerable effort) we decided to use a pan-LN driver, but use MARCM to generate sparse clones expressing dFezf. This is now clearly described in the text (Results and Discussion sections) and also included in the Materials and methods section in more detail. Briefly, in our experiments ([Figure 4I-O](#fig4){ref-type="fig"}) only L2 clones that were isolated in the column (no other lamina neuron clones present) were considered. This eliminates the possibility of non-autonomous effects from dFezf expressing clones in the same column. We also performed additional MARCM experiments using an alternative genetic background to generate an even sparser distribution of L2 clones (weaker source of Flp recombinase). This allowed a significant number of L2 neurons that were isolated in the home column, and also with respect to adjacent columns (i.e. no neighboring lamina neuron clones) to be identified. Assessment of these L2 clones produced similar results (these are shown in [Figure 4---figure supplement 1B-D](#fig4s1){ref-type="fig"}).

The dFezf mis-expression experiments to assess NetB expression were shown in 6G-J (now [Figure 7G-J](#fig7){ref-type="fig"}). We have indicated this more clearly in the main text (subsection "DFezf is necessary and sufficient for Netrin expression", last paragraph).

> The authors show that L3 terminal mis-targeting is associated with changes in the localization of presynaptic Brp puncta ([Figure 2K, L](#fig2){ref-type="fig"}), suggesting that dFezf mutant L3 neurons have defects not only in layer innervation but in synaptic partner matching. However, this analysis leaves several questions unresolved that would aid in interpreting the results. Are there quantifiable differences in the number of Brp puncta that are associated with dFezf mutant L3 neurons compared to wild type clones? Also, is there additional evidence that would support the conclusion that L3 presynaptic sites in dFezf mutants represent functioning synapses formed with ectopic partners?

We completely agree that the finding of L3 neurons still elaborating presynaptic sites within the wrong layers is provocative and could suggest a change in synaptic specificity. And that additional analyses would indeed help clarify whether this is the case. However, we feel that addressing this issue is beyond the scope of this paper for several reasons:

1\) The main conclusions of the paper do not depend on whether L3 synaptic specificity is altered beyond what we already show when dFezf is disrupted. We feel that our data provide strong evidence that connectivity with Tm9 neurons is disrupted in dFezf mutant L3 neurons, which supports the importance of dFezf for proper laminar-specific connectivity. Especially considering that the L3-Tm9 synapse is the only L3 synapse shown to be functionally and behaviorally relevant to vision. Whether, in the absence of dFezf function, L3 forms inappropriate connections addresses the degree to which connectivity is altered, which we feel is an important but separate issue.

2\) Rigorously determining if L3 forms active synapses with inappropriate targets in the absence of dFezf function requires extensive and difficult analyses, including EM (or other synaptic mapping experiments, difficult to preform rigorously at the level of light microscopy), and experiments involving optogenetic stimulation and calcium imaging to confirm EM data and demonstrate the functionality of synapses. Realistically, such studies would take at least a year and likely more to complete.

3\) We also thought about comparing the number of presynaptic sites formed between wild type and dFezf mutant L3 neurons. However, it's unclear what would be gained by this analysis. Forming more or less synapses in the absence of dFezf would not provide insight into whether synapses are active, or the cellular partners involved. In addition, differences in numbers could result from changes in gene expression caused by the loss of dFezf or result non-specifically due to an altered extracellular environment.

We have included a sentence in the main text clarifying the limitations of our data (subsection "DFezf is cell autonomously required for L3 layer specificity") so that we do not overstate our findings.

> The model strongly predicts that the FezF gain of function phenotypes should depend on induction of Netrin expression and thus should be suppressed in a Netrin mutant background. Is this the case?

We actually disagree with the reviewer comments in this case. The gain of function phenotypes we show in the paper involve mis-expression of dFezf in L2 neurons. Under these conditions, rather than terminating in the distal domain of the outer medulla in early pupal development, L2 growth cones mis-target to the proximal domain of the outer medulla. In adult animals, the dFezf expressing L2 neurons innervate the L3 target layer M3. Thus mis-expressing dFezf causes a change in broad domain specificity, and layer specificity. Our model predicts that these gain of function phenotypes are due to the cell-intrinsic function of dFezf, rather than the cell-extrinsic function involving Netrin expression. Indeed, L3 neurons and all lamina neuron subtypes innervate the correct layers in a *NetAB* null background (unpublished results).

In L3 neurons, we hypothesize that dFezf (1) represses the expression of cell surface molecules that mediate interactions with target neurons in the distal domain of the outer medulla, and (2) activates the expression of cell surface molecules that mediate interactions with targets in the proximal domain of the outer medulla, thereby directing growth cone position and laminar specificity. When mis-expressed in L2 neurons, we speculate that dFezf functions in the same way thereby altering L2 growth cone position and layer specificity.

> As the core of this paper is the function of Fezf, authors should present how Fezf works as \"a transcription factor\" in M3 layer innervation. For instance, whether can Fezf directly bind to the enhancer of Net-B gene? Which gene (gene set) expression is regulated by Fezf (probably RNA-seq data)? Alternatively, other evidence is also okay, but we suggest that the authors provide and discuss the mechanism how Fezf is involved in M3 layer targeting in more detail.

We agree with the reviewer's comments and have included the complete RNA seq-data, as well as a discussion of candidate dFezf targets relevant for growth cone targeting (see response to the first essential revisions comment above). Also, a more thorough discussion of how dFezf controls growth cone targeting is presented in the Discussion section (DFezf cell intrinsically instructs axon target specificity).

The genomic regions containing cis-regulatory elements that control *Netrin* expression have not been mapped, and given the size of the *Netrin* locus (more than 100kb) these may be complex. Our preliminary bioinformatics analysis using publicly available databases (e.g. TRANSFAC) did not identify dFezf binding motifs within the *Netrin* locus, but additional genomic studies (in progress) are necessary to rigorously assess whether *Netrin* is a direct or indirect dFezf target.

[^1]: These authors contributed equally to this work.
